<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">82619</article-id><article-id pub-id-type="doi">10.7554/eLife.82619</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Genetic architecture of heart mitochondrial proteome influencing cardiac hypertrophy</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-289212"><name><surname>Chella Krishnan</surname><given-names>Karthickeyan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4895-2495</contrib-id><email>chellakn@ucmail.uc.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-290312"><name><surname>El Hachem</surname><given-names>Elie-Julien</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5033-6117</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund12"/><xref ref-type="other" rid="fund13"/><xref ref-type="other" rid="fund14"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-131630"><name><surname>Keller</surname><given-names>Mark</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-315507"><name><surname>Patel</surname><given-names>Sanjeet G</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-224130"><name><surname>Carroll</surname><given-names>Luke</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-290313"><name><surname>Vegas</surname><given-names>Alexis Diaz</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-315508"><name><surname>Gerdes Gyuricza</surname><given-names>Isabela</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-290314"><name><surname>Light</surname><given-names>Christine</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-290315"><name><surname>Cao</surname><given-names>Yang</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-290316"><name><surname>Pan</surname><given-names>Calvin</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-290317"><name><surname>Kaczor-Urbanowicz</surname><given-names>Karolina Elżbieta</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-290318"><name><surname>Shravah</surname><given-names>Varun</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-290319"><name><surname>Anum</surname><given-names>Diana</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-256030"><name><surname>Pellegrini</surname><given-names>Matteo</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-290320"><name><surname>Lee</surname><given-names>Chi Fung</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-212053"><name><surname>Seldin</surname><given-names>Marcus M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8026-4759</contrib-id><xref ref-type="aff" rid="aff14">14</xref><xref ref-type="aff" rid="aff15">15</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-159382"><name><surname>Rosenthal</surname><given-names>Nadia A</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18535"><name><surname>Churchill</surname><given-names>Gary A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9190-9284</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-252204"><name><surname>Attie</surname><given-names>Alan</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con19"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-236112"><name><surname>Parker</surname><given-names>Benjamin</given-names></name><xref ref-type="aff" rid="aff16">16</xref><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con20"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94836"><name><surname>James</surname><given-names>David E</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5946-5257</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con21"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-22114"><name><surname>Lusis</surname><given-names>Aldons J</given-names></name><email>JLusis@mednet.ucla.edu</email><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="aff" rid="aff17">17</xref><xref ref-type="aff" rid="aff18">18</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund10"/><xref ref-type="other" rid="fund11"/><xref ref-type="fn" rid="con22"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01e3m7079</institution-id><institution>Department of Pharmacology and Systems Physiology, University of Cincinnati College of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Cincinnati</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/001z21q04</institution-id><institution>Department of Integrative Biology and Physiology, Field Systems Biology, Sciences Sorbonne Université</institution></institution-wrap><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01y2jtd41</institution-id><institution>Biochemistry Department, University of Wisconsin-Madison</institution></institution-wrap><addr-line><named-content content-type="city">Madison</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03taz7m60</institution-id><institution>Department of Surgery/Division of Cardiac Surgery, University of Southern California Keck School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Los Angeles</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0384j8v12</institution-id><institution>Metabolic Systems Biology Laboratory, Charles Perkins Centre, School of Life and Environmental Sciences, University of Sydney</institution></institution-wrap><addr-line><named-content content-type="city">Sydney</named-content></addr-line><country>Australia</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/021sy4w91</institution-id><institution>Jackson Laboratory</institution></institution-wrap><addr-line><named-content content-type="city">Bar Harbor</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/035z6xf33</institution-id><institution>Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation</institution></institution-wrap><addr-line><named-content content-type="city">Oklahoma City</named-content></addr-line><country>United States</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>Department of Medicine/Division of Cardiology, University of California, Los Angeles</institution></institution-wrap><addr-line><named-content content-type="city">Los Angeles</named-content></addr-line><country>United States</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>Division of Oral Biology and Medicine, UCLA School of Dentistry</institution></institution-wrap><addr-line><named-content content-type="city">Los Angeles</named-content></addr-line><country>United States</country></aff><aff id="aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>UCLA Institute for Quantitative and Computational Biosciences</institution></institution-wrap><addr-line><named-content content-type="city">Los Angeles</named-content></addr-line><country>United States</country></aff><aff id="aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>Department of Chemistry, University of California</institution></institution-wrap><addr-line><named-content content-type="city">Los Angeles</named-content></addr-line><country>United States</country></aff><aff id="aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>Department of Integrative Biology and Physiology, University of California</institution></institution-wrap><addr-line><named-content content-type="city">Los Angeles</named-content></addr-line><country>United States</country></aff><aff id="aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0457zbj98</institution-id><institution>Department of Physiology, University of Oklahoma Health Sciences Center</institution></institution-wrap><addr-line><named-content content-type="city">Oklahoma City</named-content></addr-line><country>United States</country></aff><aff id="aff14"><label>14</label><institution>Center for Epigenetics and Metabolism</institution><addr-line><named-content content-type="city">Irvine</named-content></addr-line><country>United States</country></aff><aff id="aff15"><label>15</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04gyf1771</institution-id><institution>Department of Biological Chemistry, University of California</institution></institution-wrap><addr-line><named-content content-type="city">Irvine</named-content></addr-line><country>United States</country></aff><aff id="aff16"><label>16</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01ej9dk98</institution-id><institution>Department of Anatomy and Physiology, University of Melbourne</institution></institution-wrap><addr-line><named-content content-type="city">Melbourne</named-content></addr-line><country>Australia</country></aff><aff id="aff17"><label>17</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>Department of Human Genetics, University of California</institution></institution-wrap><addr-line><named-content content-type="city">Los Angeles</named-content></addr-line><country>United States</country></aff><aff id="aff18"><label>18</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>Department of Microbiology, Immunology and Molecular Genetics, University of California</institution></institution-wrap><addr-line><named-content content-type="city">Los Angeles</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Ardehali</surname><given-names>Hossein</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/000e0be47</institution-id><institution>Northwestern University</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Barton</surname><given-names>Matthias</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02crff812</institution-id><institution>University of Zurich</institution></institution-wrap><country>Switzerland</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>05</day><month>06</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e82619</elocation-id><history><date date-type="received" iso-8601-date="2022-08-11"><day>11</day><month>08</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-05-18"><day>18</day><month>05</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-08-26"><day>26</day><month>08</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.08.24.505177"/></event></pub-history><permissions><copyright-statement>© 2023, Chella Krishnan et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Chella Krishnan et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-82619-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-82619-figures-v1.pdf"/><abstract><p>Mitochondria play an important role in both normal heart function and disease etiology. We report analysis of common genetic variations contributing to mitochondrial and heart functions using an integrative proteomics approach in a panel of inbred mouse strains called the Hybrid Mouse Diversity Panel (HMDP). We performed a whole heart proteome study in the HMDP (72 strains, n=2-3 mice) and retrieved 848 mitochondrial proteins (quantified in ≥50 strains). High-resolution association mapping on their relative abundance levels revealed three <italic>trans</italic>-acting genetic loci on chromosomes (chr) 7, 13 and 17 that regulate distinct classes of mitochondrial proteins as well as cardiac hypertrophy. DAVID enrichment analyses of genes regulated by each of the loci revealed that the chr13 locus was highly enriched for complex-I proteins (24 proteins, <italic>P</italic>=2.2E-61), the chr17 locus for mitochondrial ribonucleoprotein complex (17 proteins, <italic>P</italic>=3.1E-25) and the chr7 locus for ubiquinone biosynthesis (3 proteins, <italic>P</italic>=6.9E-05). Follow-up high resolution regional mapping identified NDUFS4, LRPPRC and COQ7 as the candidate genes for chr13, chr17 and chr7 loci, respectively, and both experimental and statistical analyses supported their causal roles. Furthermore, a large cohort of Diversity Outbred mice was used to corroborate <italic>Lrpprc</italic> gene as a driver of mitochondrial DNA (mtDNA)-encoded gene regulation, and to show that the chr17 locus is specific to heart. Variations in all three loci were associated with heart mass in at least one of two independent heart stress models, namely, isoproterenol-induced heart failure and diet-induced obesity. These findings suggest that common variations in certain mitochondrial proteins can act in <italic>trans</italic> to influence tissue-specific mitochondrial functions and contribute to heart hypertrophy, elucidating mechanisms that may underlie genetic susceptibility to heart failure in human populations.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>proteomics</kwd><kwd>metabolic syndrome</kwd><kwd>genetic, association studies</kwd><kwd>mitochondria</kwd><kwd>hypertrophy</kwd><kwd>heart failure</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>DK120342</award-id><principal-award-recipient><name><surname>Lusis</surname><given-names>Aldons J</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R00DK120875</award-id><principal-award-recipient><name><surname>Chella Krishnan</surname><given-names>Karthickeyan</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R00HL138193</award-id><principal-award-recipient><name><surname>Seldin</surname><given-names>Marcus M</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01DK101573</award-id><principal-award-recipient><name><surname>Attie</surname><given-names>Alan</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000005</institution-id><institution>U.S. Department of Defense</institution></institution-wrap></funding-source><award-id>W81XWH2110115</award-id><principal-award-recipient><name><surname>Lusis</surname><given-names>Aldons J</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001395</institution-id><institution>Wisconsin Alumni Research Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Keller</surname><given-names>Mark</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000925</institution-id><institution>National Health and Medical Research Council</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Parker</surname><given-names>Benjamin</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01DK102948</award-id><principal-award-recipient><name><surname>Attie</surname><given-names>Alan</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>RC2DK125961</award-id><principal-award-recipient><name><surname>Attie</surname><given-names>Alan</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>HL148577</award-id><principal-award-recipient><name><surname>Lusis</surname><given-names>Aldons J</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>HL147883</award-id><principal-award-recipient><name><surname>Lusis</surname><given-names>Aldons J</given-names></name></principal-award-recipient></award-group><award-group id="fund12"><funding-source><institution-wrap><institution>Systems Biology Association fellowship</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>El Hachem</surname><given-names>Elie-Julien</given-names></name></principal-award-recipient></award-group><award-group id="fund13"><funding-source><institution-wrap><institution>Foundation Sorbonne fellowship</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>El Hachem</surname><given-names>Elie-Julien</given-names></name></principal-award-recipient></award-group><award-group id="fund14"><funding-source><institution-wrap><institution>French Minister and Master BIP</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>El Hachem</surname><given-names>Elie-Julien</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The discovery of three distinct and independent trans-regulating genomic loci influencing heart mass using a well-characterized mouse reference population provides evidence in support of the hypothesis that genetic diversity in the mitochondrial proteome plays a critical role in heart pathophysiology.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Mitochondrial functions play a major role in the pathophysiology of several metabolic syndrome traits including obesity, insulin resistance and fatty liver disease (<xref ref-type="bibr" rid="bib82">Yin et al., 2014</xref>; <xref ref-type="bibr" rid="bib13">Chouchani et al., 2014</xref>; <xref ref-type="bibr" rid="bib4">Begriche et al., 2006</xref>; <xref ref-type="bibr" rid="bib63">Sanyal et al., 2001</xref>; <xref ref-type="bibr" rid="bib32">Kim et al., 2008</xref>). There is now substantial evidence showing that genetic variation in mitochondrial functions contribute importantly to ‘complex’ diseases such as cardiovascular diseases (CVD) (<xref ref-type="bibr" rid="bib74">Wallace, 2018</xref>). A scientific statement from the American Heart Association summarizes the central role of mitochondria in heart disease (<xref ref-type="bibr" rid="bib48">Murphy et al., 2016</xref>). Mitochondrial bioenergetics and other functions impinge on virtually all aspects of the cell, including energy, cellular redox, apoptosis, and substrates for epigenetic modifications. Mitochondrial dysfunction also contributes to the development of heart failure (<xref ref-type="bibr" rid="bib6">Brown et al., 2017</xref>; <xref ref-type="bibr" rid="bib86">Zhou and Tian, 2018</xref>). The primary putative mechanism linking mitochondrial dysfunction to heart failure is decreased oxidative respiration leading to contractile failure. However, many other mechanisms have been postulated in recent years to implicate mitochondrial dysfunction in heart failure. They include excessive oxidative stress leading to inflammation, cell damage, and cell death; disturbed calcium homeostasis that triggers the opening of the mitochondrial permeability transition pore (mPTP), leading to loss of membrane potential, and eventual cell death. Therefore, mitochondria are an attractive target for heart failure therapy (<xref ref-type="bibr" rid="bib6">Brown et al., 2017</xref>). Despite evidence showing that genetic variation in mitochondrial proteins is linked to disease, most studies tend to overlook the role of genetic variation in exploring the link between mitochondrial function and relevant phenotypes. To this end, we employ a ‘systems genetics’ approach to address this issue.</p><p>Our laboratory uses a combination of genetics, molecular biology, and informatics to investigate pathways underlying common cardiovascular and metabolic disorders. We exploit natural genetic variation among inbred strains of mice (and among human populations where possible) to identify novel targets and formulate hypotheses, taking advantage of unbiased global multi-omics technologies, such as transcriptomics, metabolomics, and proteomics, to help decipher causal mechanisms that drive complex traits. This ‘systems genetics’ approach integrates natural genetic variation with omics-level data (such as global protein abundance levels) to examine complex interactions that are difficult to address directly in humans. It shares with systems biology a holistic, global perspective (<xref ref-type="bibr" rid="bib15">Civelek and Lusis, 2014</xref>; <xref ref-type="bibr" rid="bib67">Seldin et al., 2019</xref>). Typically, a genetic reference population is examined for relevant clinical traits as well as global molecular traits, such as proteomics, and the data are integrated using correlation structure, genetic mapping, and mathematical modeling (<xref ref-type="bibr" rid="bib15">Civelek and Lusis, 2014</xref>; <xref ref-type="bibr" rid="bib67">Seldin et al., 2019</xref>).</p><p>Our systems genetics approach utilizes a well-characterized genetic reference population of 100 inbred mice strains, termed the Hybrid Mouse Diversity Panel (HMDP) (<xref ref-type="bibr" rid="bib44">Lusis et al., 2016</xref>). The design of the HMDP resource, consisting of a panel of permanent inbred strains of mice that can be examined for many phenotypes, has proved invaluable for studying metabolic syndrome traits. Major advantages of this approach are that the mapping resolution for complex traits is superior to traditional genetic crosses and the use of inbred strains affords replication of biological measures. It also facilitates studies of gene-by-environment and gene-by-sex interactions, which are difficult to address in human populations. Using this resource, we have characterized several cardiometabolic traits in both sexes over the last 10 years (<xref ref-type="bibr" rid="bib55">Parks et al., 2013</xref>; <xref ref-type="bibr" rid="bib56">Parks et al., 2015</xref>; <xref ref-type="bibr" rid="bib59">Rau et al., 2015</xref>; <xref ref-type="bibr" rid="bib54">Org et al., 2016</xref>; <xref ref-type="bibr" rid="bib77">Wang et al., 2016</xref>; <xref ref-type="bibr" rid="bib65">Seldin et al., 2017</xref>; <xref ref-type="bibr" rid="bib60">Rau et al., 2017</xref>; <xref ref-type="bibr" rid="bib50">Norheim et al., 2017</xref>; <xref ref-type="bibr" rid="bib51">Norheim et al., 2018</xref>; <xref ref-type="bibr" rid="bib24">Hui et al., 2018</xref>; <xref ref-type="bibr" rid="bib66">Seldin et al., 2018</xref>; <xref ref-type="bibr" rid="bib10">Chella Krishnan et al., 2018</xref>; <xref ref-type="bibr" rid="bib11">Chella Krishnan et al., 2019</xref>; <xref ref-type="bibr" rid="bib52">Norheim et al., 2019</xref>; <xref ref-type="bibr" rid="bib12">Chella Krishnan et al., 2021</xref>).</p><p>In the present study, we have explored the genetic regulation of mitochondrial pathways and their contribution to heart function in the HMDP. Using an integrative proteomics approach, we now report the identification of three independent genetic loci that control distinct classes of mitochondrial proteins as well as heart hypertrophy. Each locus contains proteins previously shown to affect heart pathophysiology but by unknown mechanisms. Our results show that genetic diversity in the mitochondrial proteome plays a central role in heart pathophysiology.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Genetic architecture of the heart mitochondrial proteome revealed three <italic>trans</italic>-regulatory hotspots</title><p>To investigate the effects of genetics on the heart proteome, we first performed a whole heart proteomic analysis in the HMDP (72 strains, n=2–3 mice, female sex; listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>) and surveyed mitochondrial localization using MitoCarta3.0 (<xref ref-type="bibr" rid="bib58">Rath et al., 2021</xref>). We retrieved abundance data for 848 of these proteins (quantified in ≥50 strains) and performed high-resolution association mapping on their respective abundance levels to the HMDP genotypes. Genetic variants associated to the protein abundance of nearby genes (&lt;1 Mb) were referred to as <italic>cis</italic>- protein quantitative trait loci (pQTLs) and the remainder were referred to as <italic>trans</italic>-pQTLs. When a <italic>trans</italic>-pQTL locus is associated to multiple proteins, we defined it as a <italic>trans</italic>-pQTL hotspot. Using these criteria, we identified three hotspots, located on chromosome (chr) 7, chr13 and chr17, respectively (<xref ref-type="fig" rid="fig1">Figure 1A</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Genetic architecture of heart mitochondrial proteome.</title><p>(<bold>A</bold>) High-resolution association mapping of 848 heart mitochondrial proteins from 72 HMDP strains to identify pQTL networks. Associations between protein abundance levels and genetic variants located within 1 Mb of the respective gene location were considered as <italic>cis</italic>-pQTLs (p&lt;1E-05) shown along the diagonal axis and the rest were considered as <italic>trans</italic>-pQTLs (p&lt;1E-06). Three <italic>trans</italic>-pQTL hotspots are indicated by arrows. (<bold>B</bold>) Five WGCNA modules and the respective <italic>trans</italic>-pQTL hotspots are shown. HMDP, hybrid mouse diversity panel; pQTL, protein quantitative trait locus; WGCNA, weighted gene co-expression network analysis.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82619-fig1-v1.tif"/></fig><p>To identify the aspects of mitochondrial metabolism regulated by these loci, we constructed co-expression protein networks using weighted gene co-expression network analysis (WGCNA; <xref ref-type="bibr" rid="bib35">Langfelder and Horvath, 2008</xref>) and identified five modules (<xref ref-type="fig" rid="fig1">Figure 1B</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>). Eigengenes, representing the first principal component of two of these modules (Brown and Green), mapped to the same regions as the chr13 and chr17 loci, respectively. DAVID enrichment analyses (<xref ref-type="bibr" rid="bib23">Huang et al., 2009</xref>) revealed that the chr13 locus (26 proteins; <xref ref-type="fig" rid="fig2">Figure 2A</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1c</xref>) that overlapped with Brown module (67 proteins, 96% overlap) was highly enriched for mitochondrial complex-I proteins (24 proteins, p=2.2E-61), and the chr17 locus (22 proteins; <xref ref-type="fig" rid="fig3">Figure 3A</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1d</xref>) that overlapped with Green module (38 proteins, 73% overlap) was highly enriched for mitochondrial ribonucleoprotein complex proteins (17 proteins, p=3.1E-25). The hotspot proteins in the chr7 locus (26 proteins; <xref ref-type="fig" rid="fig4">Figure 4A</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1e</xref>) were found primarily in the Turquoise module (402 proteins, 81% overlap) and was highly enriched for ubiquinone biosynthesis (3 proteins, p=6.9E-05).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Chr13 locus controls mitochondrial complex-I <italic>via miR-27b</italic>/NDUFS4 axis.</title><p>(<bold>A</bold>) Circos plot showing chr13 hotspot. Each line signifies a significant association between the genetic variants and the respective protein levels with candidate genes being highlighted. (<bold>B</bold>) Manhattan and regional plots of chr13 locus (brown module) eigengene, respectively. Red line signifies genome-wide significance threshold (p&lt;4.1E-06). The peak SNPs and the candidate genes are highlighted. Genotype distribution plots of (<bold>C</bold>) protein levels and eigengenes, and cardiac phenotypes from (<bold>D</bold>) ISO-induced HF model and (<bold>E</bold>) female and (<bold>F</bold>) male DIO model at peak SNP (rs48592660) associated with chr13 locus. (<bold>G</bold>) Volcano plot showing differentially expressed protein levels between control and heart-specific <italic>Ndufs4</italic>-cKO mice (n=5 mice/group). Significantly different proteins (significance cutoff: abs[log<sub>2</sub>FC]&gt;1 and P<sub>adj</sub> &lt;0.001) are highlighted in red. (<bold>H</bold>) Genotype distribution plots of heart <italic>miR-27b</italic> expression at peak SNP (rs48592660) associated with chr13 locus. (<bold>I</bold>) Gene-by-trait correlation plot between heart weight phenotype and heart <italic>miR-27b</italic> expression. (<bold>J</bold>) Immunoblot analyses of NDUFS4 protein levels in NRVMs transfected with mature <italic>miR-27b</italic> in the presence or absence of PE treatment. Data are presented as (<bold>C–F and H</bold>) boxplots showing median and interquartile range with outliers shown as circles (n=68–72 strains for protein levels; n=92–95 strains for ISO-model; n=92–100 strains for DIO-model; n=78 strains for miRNA levels) or (<bold>J</bold>) mean ± SEM (n=4–6 per group). p Values were calculated using (<bold>A and B</bold>) FaST-LMM that uses Likelihood-Ratio test; (<bold>C–F and H</bold>) Unpaired two-tailed Student’s t test; (<bold>I</bold>) BicorAndPvalue function of the WGCNA R-package that uses Unpaired two-tailed Student’s t test; (<bold>J</bold>) two-factor ANOVA corrected by post-hoc “Holm-Sidak’s” multiple comparisons test. ISO, isoproterenol; HF, heart failure; DIO, diet-induced obesity; NRVMs, neonatal rat ventricular myocytes; PE, phenylephrine.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Uncropped blots for <xref ref-type="fig" rid="fig2">Figure 2</xref>, panel J.</title><p>Uncropped immunoblots probed for NDUFS4 (left) and ACTIN (right) protein levels in NRVMs transfected with mature miR-27b in the presence or absence of PE treatment. Corresponding molecular weight markers are labelled on the right side of each blot.</p></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-82619-fig2-data1-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Raw unedited and uncropped blots for <xref ref-type="fig" rid="fig2">Figure 2</xref>, panel J.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-82619-fig2-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82619-fig2-v1.tif"/></fig><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Chr17 locus controls mitoribosomes <italic>via</italic> LRPPRC/SLIRP.</title><p>(<bold>A</bold>) Circos plot showing chr17 hotspot. Each line signifies a significant association between the genetic variants and the respective protein levels with candidate genes being highlighted. (<bold>B</bold>) Manhattan and regional plots of chr17 locus (green module) eigengene, respectively. Red line signifies genome-wide significance threshold (<italic>P</italic>&lt;4.1E-06). The peak SNPs and the candidate genes are highlighted. Genotype distribution plots of (<bold>C</bold>) protein levels and eigengenes, and cardiac phenotypes from (<bold>D</bold>) ISO-induced HF model and (<bold>E</bold>) female and (<bold>F</bold>) male DIO model at peak SNP (rs46340181) associated with chr17 locus. (<bold>G</bold>) Protein-by-protein correlation plot between heart LRPPRC and SLIRP abundance levels. (<bold>H</bold>) Association p values between mtDNA-encoded mRNA expression or protein abundance levels and peak SNP (rs46340181) associated with chr17 locus in both sexes of HMDP. (<bold>I</bold>) Genotype distribution plots of heart <italic>mt-ND1</italic> mRNA expression from female and male DIO model at peak SNPs associated with chr17 (rs46340181) or chr13 (rs48592660) loci, respectively. (<bold>J</bold>) Association p values between mtDNA-encoded complex-I related mRNA expression or protein abundance levels and peak SNP (rs48592660) associated with chr13 locus in both sexes of HMDP. Data are presented as (<bold>C–F and I</bold>) boxplots showing median and interquartile range with outliers shown as circles (n=68–72 strains for protein levels; n=92–95 strains for ISO-model; n=92–100 strains for DIO-model). p Values were calculated using (<bold>A, B, H and J</bold>) FaST-LMM that uses Likelihood-Ratio test; (<bold>C–F and I</bold>) Unpaired two-tailed Student’s t test; (<bold>G</bold>) BicorAndPvalue function of the WGCNA R-package that uses Unpaired two-tailed Student’s t test.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Raw data for <xref ref-type="fig" rid="fig3">Figure 3</xref>, panel H.</title><p>Association p values between mtDNA-encoded mRNA expression or protein abundance levels and peak SNP (rs46340181) associated with chr17 locus in both sexes of HMDP. p Values were calculated using FaST-LMM that uses Likelihood-Ratio test.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-82619-fig3-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Raw data for <xref ref-type="fig" rid="fig3">Figure 3</xref>, panel J.</title><p>Association p values between mtDNA-encoded complex-I related mRNA expression or protein abundance levels and peak SNP (rs48592660) associated with chr13 locus in both sexes of HMDP. p Values were calculated using FaST-LMM that uses Likelihood-Ratio test.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-82619-fig3-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82619-fig3-v1.tif"/></fig><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title><italic>Lrpprc</italic> regulates an mt-encoded eQTL hotspot specifically in heart of DO mice.</title><p>(<bold>A</bold>) Heatmap illustrates all eQTL (LOD &gt;6) for mt-encoded transcripts that were identified in Adipose (<xref ref-type="bibr" rid="bib75">Wang et al., 2012</xref>), Heart (<xref ref-type="bibr" rid="bib62">Ruzzenente et al., 2012</xref>), Islet (<xref ref-type="bibr" rid="bib20">Gu et al., 2016</xref>), Liver (<xref ref-type="bibr" rid="bib58">Rath et al., 2021</xref>), and Muscle (<xref ref-type="bibr" rid="bib77">Wang et al., 2016</xref>) from Diversity Outbred mice maintained on a Western-style diet. Mt-eQTL are arranged along x-axis according to genomic position from chr1 to chrX; z-axis depicts LOD score, highlighting a hotspot on chr17 at ~85 Mbp. (<bold>B</bold>) Allele effect patterns for mt-eQTL mapping to chr17 hotspot in heart. Red illustrates alleles associated with increased expression; blue, decreased expression. LOD scores are shown along right margin. (<bold>C</bold>) SNP association profile for mt-Nd5 eQTL in heart. <italic>Lrpprc</italic> contains SNPs with strongest association, yellow highlighted region. (<bold>D</bold>) Mediation of mt-Nd5 eQTL against all transcripts in heart. The LOD score for mt-Nd5 is significantly reduced when conditioned on a <italic>Lrpprc</italic> cis-eQTL, consistent with genetic regulation of <italic>Lrpprc</italic> being required for the regulation of mt-Nd5. The mt-Nd5 eQTL (<bold>E</bold>) and <italic>Lrpprc</italic> cis-eQTL (<bold>F</bold>) in heart demonstrate matched and concordant allele effect patterns, suggesting <italic>Lrpprc</italic> is a positive driver of mt-Nd5.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82619-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Mediation analysis identifies Lrpprc as a driver for the heart-specific mt- eQTL hotspot on chr17.</title><p>LOD scores for 14 mt-eQTL at ~85 Mbp on chr17 before and after conditioning on Lrpprc cis-eQTL in the heart. The average percent drop in the LOD score for the mt-eQTL upon condition to Lrpprc was 79%, with a range of 51% (mt-Co2) to 94% (mt-Rnr2).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82619-fig4-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-2"><title>Chr13 locus controls mitochondrial complex-I</title><p>First, we analyzed the chr13 locus (26 proteins) that was highly enriched for mitochondrial complex-I (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Mapping the eigengene of the chr13 <italic>trans</italic>-regulated proteins identified the peak SNP (rs48592660). NDUFS4, a protein critical for complex-I assembly and loss of which leads to cardiac hypertrophy (<xref ref-type="bibr" rid="bib13">Chouchani et al., 2014</xref>) mapped near the locus but outside the region of linkage disequilibrium. However, within the locus was the <italic>microRNA(miR)–23b/27b/24–1</italic> cluster, among which <italic>miR-27b</italic>, a conserved regulator of NDUFS4, was identified <italic>via</italic> nine miRNA target prediction algorithms and one dataset of experimentally validated miRNA targets (<xref ref-type="fig" rid="fig2">Figure 2B</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1f</xref>). Cardiac overexpression of <italic>miR-27b</italic> has previously been shown to promote cardiac hypertrophy (<xref ref-type="bibr" rid="bib75">Wang et al., 2012</xref>) but attenuate angiotensin II-induced atrial fibrosis (<xref ref-type="bibr" rid="bib78">Wang et al., 2018</xref>). We therefore hypothesized that the chr13 locus regulated complex-I proteins by influencing <italic>miR-27b</italic> and thus NDUFS4 protein levels. Indeed, we observed higher levels of both the chr13 locus eigengene and NDUFS4 with the GG allele of the peak locus SNP (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). To identify the functional relevance of this peak SNP, we analyzed its association in two independent heart stress models, namely, isoproterenol (ISO)-induced heart failure (<xref ref-type="bibr" rid="bib77">Wang et al., 2016</xref>) and diet-induced obesity (DIO) (<xref ref-type="bibr" rid="bib55">Parks et al., 2013</xref>) models. We observed significantly lower left ventricular mass under ISO stress (<xref ref-type="fig" rid="fig2">Figure 2D</xref>) and lower heart weight under DIO stress in both sexes (<xref ref-type="fig" rid="fig2">Figure 2E</xref>) of strains harboring the GG allele, thus confirming the directionality of genetic impacts on NDUFS4 protein levels and hypertrophic response.</p></sec><sec id="s2-3"><title>NDUFS4 heart-specific knockout mice had reduced mitochondrial complex-I proteins</title><p>NDUFS4 is an 18 kDa accessory subunit that is essential for the mitochondrial complex-I assembly (<xref ref-type="bibr" rid="bib87">Zhu et al., 2016</xref>; <xref ref-type="bibr" rid="bib71">Stroud et al., 2016</xref>; <xref ref-type="bibr" rid="bib20">Gu et al., 2016</xref>; <xref ref-type="bibr" rid="bib25">Kahlhöfer et al., 2017</xref>; <xref ref-type="bibr" rid="bib64">Scacco et al., 2003</xref>). Loss-of-function mutations in NDUFS4 leads to complex-I deficiency causing a neuromuscular disease, Leigh syndrome (<xref ref-type="bibr" rid="bib40">Leshinsky-Silver et al., 2009</xref>) and is also involved in cardiomyopathies (<xref ref-type="bibr" rid="bib13">Chouchani et al., 2014</xref>; <xref ref-type="bibr" rid="bib28">Karamanlidis et al., 2013</xref>; <xref ref-type="bibr" rid="bib84">Zhang et al., 2018</xref>). Taken together, we wanted to experimentally test our hypothesis that NDUFS4 protein independently controls the complex-I protein abundance levels in heart. For this, we performed whole heart proteomic analyses in both control and heart-specific <italic>Ndufs4</italic>-cKO mice (n=5 mice/group). Among the abundance data for 3575 proteins, we observed 31 proteins to be significantly different between the control and cKO groups (significance cutoff: abs[log<sub>2</sub>FC]&gt;1 and P<sub>adj</sub> &lt;0.001; listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1g</xref>). Strikingly, 21 of these proteins were found in the chr13 locus and these were highly enriched for complex-I proteins (30 proteins, p=3.8E-80). Notably, only one protein, NDUFAF2, was up regulated in <italic>Ndufs4</italic>-cKO mice (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). This is intriguing because NDUFAF2 has been reported to stabilize complex-I in the absence of NDUFS4 and to sustain complex-I activity (<xref ref-type="bibr" rid="bib1">Adjobo-Hermans et al., 2020</xref>; <xref ref-type="bibr" rid="bib39">Leong et al., 2012</xref>) indicating this may be a compensatory mechanism.</p></sec><sec id="s2-4"><title><italic>MiR-27b</italic> controls NDUFS4 protein levels and heart weights</title><p>As an independent corroboration and to understand the consequence of the chr13 locus on <italic>miR-27b</italic> expression, we independently sequenced miRNAs from DIO-stressed female HMDP strains (n=78 strains). We found that strains harboring the GG allele had higher <italic>miR-27b</italic> expression (<xref ref-type="fig" rid="fig2">Figure 2H</xref>), and there was a significant inverse correlation between heart weights and <italic>miR-27b</italic> expression in these mice (<xref ref-type="fig" rid="fig2">Figure 2I</xref>). Based on these observations, we hypothesize that <italic>miR-27b</italic> increases NDUFS4 protein levels thereby reducing heart weights. To validate this observation, we transfected neonatal rat ventricular myocytes (NRVMs) with mature <italic>miR-27b</italic> in the presence or absence of phenylephrine (PE) treatment. The precursor miR-27b has two mature arms: miR-27b-5p and miR-27b-3p that originates from the 5’ or 3’ strand of the precursor miR-27b, respectively and are almost complementary to each other. The stability and functionality of each arm depends on the tissue/cell type and according to miRBase Sequence database (<xref ref-type="bibr" rid="bib34">Kozomara and Griffiths-Jones, 2011</xref>) (database of published miRNA sequences and annotation), miR-27b-3p (98.8%) is more abundant than miR-27b-5p (1.2%) and therefore is assumed to be the stable and functional version. Immunoblot analyses revealed that NDUFS4 protein levels were reduced with PE treatment in the control cells but <italic>miR-27b-3p</italic> consistently increased NDUFS4 protein levels in both control and PE-treated conditions while <italic>miR-27b-5p</italic> increased NDUFS4 protein levels only in the PE-treated conditions (<xref ref-type="fig" rid="fig2">Figure 2J</xref>). Taken together, we conclude that the chr13 locus affects mitochondrial complex-I proteins through the <italic>miR-27b</italic>/NDUFS4 axis, thereby controlling heart weights.</p></sec><sec id="s2-5"><title>Chr17 locus controls mitoribosomes</title><p>Next, we analyzed the chr17 locus (22 proteins) that was highly enriched for mitochondrial ribosomal proteins (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). We mapped the eigengene of the significantly associated mitochondrial proteins to identify the peak SNP (rs46340181). We identified LRPPRC as a candidate as it was the only protein controlled in cis by the peak SNP (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Importantly, LRPPRC together with SLIRP controls mitochondrial mRNA stability, enabling polyadenylation and translation (<xref ref-type="bibr" rid="bib69">Siira et al., 2017</xref>; <xref ref-type="bibr" rid="bib14">Chujo et al., 2012</xref>; <xref ref-type="bibr" rid="bib62">Ruzzenente et al., 2012</xref>). Loss-of-function mutations in LRPPRC cause a congenital mitochondrial disease called Leigh syndrome, French-Canadian type that is often characterized by mitochondrial complex IV deficiency and impaired mitochondrial respiration and in some cases, neonatal cardiomyopathy and congenital cardiac abnormalities have been reported (<xref ref-type="bibr" rid="bib46">Mootha et al., 2003</xref>; <xref ref-type="bibr" rid="bib53">Oláhová et al., 2015</xref>). It is noteworthy that SLIRP is also under the control of the chr17 locus (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Further, our phenotypic associations revealed that the eigengene and LRPPRC were inversely associated with the TT allele (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). This was functionally translated into lower heart weight in strains harboring the TT allele in both sexes under DIO stress only (<xref ref-type="fig" rid="fig3">Figure 3D–F</xref>). We also observed that abundance levels of both LRPPRC and SLIRP proteins were strongly correlated with each other (<xref ref-type="fig" rid="fig3">Figure 3G</xref>) and controlled by the chr17 locus (<xref ref-type="fig" rid="fig3">Figure 3A</xref>), thus demonstrating that they are co-regulated.</p></sec><sec id="s2-6"><title>LRPPRC/SLIRP protein complex controls mitochondrial transcript levels</title><p>Based on our current observations and published data, we hypothesized that high LRPPRC/SLIRP protein complex stabilizes mitochondrial transcripts, thus reducing the need to upregulate mitochondrial translation. To test this, we independently sequenced the heart transcripts from our HMDP mice that underwent DIO stress. We observed that the chr17 locus peak SNP (rs46340181), which strongly controls both LRPPRC and SLIRP proteins, is only associated with the mitochondrial mRNA expression and not their respective protein levels (<xref ref-type="fig" rid="fig3">Figure 3H</xref>). Moreover, this phenomenon was observed in both sexes, explaining the lack of sex bias in phenotypic associations (<xref ref-type="fig" rid="fig3">Figure 3E and F</xref>). In contrast, the chr13 locus that controlled complex-I proteins did not show strong associations with transcript levels in either sex (<xref ref-type="fig" rid="fig3">Figure 3I and J</xref>). As a specific example, <xref ref-type="fig" rid="fig3">Figure 3I</xref> shows that the mRNA expression of <italic>mt-ND1</italic> was higher in strains harboring the TT allele in both sexes under DIO stress, illustrating that upregulated LRPPRC/SLIRP is stabilizing the mitochondrial transcript (<xref ref-type="fig" rid="fig3">Figure 3C</xref>), resulting in reduced heart weights (<xref ref-type="fig" rid="fig3">Figure 3D–F</xref>).</p></sec><sec id="s2-7"><title>Corroboration with Diversity Outbred mice also identifies a heart-specific chr17 mt-eQTL hotspot controlled by LRPPRC</title><p>As independent corroboration, we utilized the Diversity Outbred (DO) mice (<xref ref-type="bibr" rid="bib73">Svenson et al., 2012</xref>) to further explore our chr17 locus. To extend our observations about the genetics of mitochondrially encoded (mt-encoded) gene regulation, we asked if mt-encoded genes are subjected to genetic regulation in multiple tissues from a large cohort of DO mice. We used RNA-sequencing to survey gene expression that included transcripts encoded by the mitochondrial genome, in five tissues (adipose, heart, islet, liver and skeletal muscle) from ~500 DO mice that were maintained on a Western-style diet high in fat and sucrose. All DO mice were genotyped at &gt;140 K SNPs with the GigaMUGA microarray (<xref ref-type="bibr" rid="bib47">Morgan et al., 2015</xref>), enabling eQTL analysis of the mt-encoded transcripts. Among the five tissues surveyed, we identified 157 mt-eQTL (LOD &gt;6) for 15 mt-encoded genes, including all 13 protein-coding genes, and the two genes that encode for ribosomal RNA proteins (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1h</xref>). Given that the mitochondrial and nuclear genomes are distinct, mt-encoded eQTL at nuclear loci reflect trans-acting mechanisms that bridge the two genomes (<xref ref-type="bibr" rid="bib3">Ali et al., 2019</xref>).</p><p>While all tissues yielded multiple mt-eQTL, heart demonstrated a striking hotspot where 14 mt-encoded genes uniquely mapped to chr17 at ~85 Mbp with LOD scores ranging from 52 (mt-Nd5) to 6 (mt-Co2) (<xref ref-type="fig" rid="fig4">Figure 4A</xref>; listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1h</xref>). The founder allele-effect signatures for the 14 mt-eQTL at the hotspot were the same and partitioned the eight haplotypes into ‘high’ (A/J, B6, 129, WSB) versus ‘low’ (NOD, NZO, CAST, PWK) subgroups (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), suggesting a common causal variant behind the co-mapping of the mt-eQTL. The SNP association profile for the mt-Nd5 eQTL identified a block of SNPs directly over the <italic>Lrpprc</italic> gene locus (<xref ref-type="fig" rid="fig4">Figure 4C</xref>), including one missense variant (rs33393440, Lys466Glu), which is present in the high allele subgroup (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1i</xref>). Taken together, these results suggest that SNPs within <italic>Lrpprc</italic> may be responsible for the heart-specific mt-eQTL hotspot.</p><p>We used mediation analysis to identify potential causal gene underlying physiological or molecular QTL as described (<xref ref-type="bibr" rid="bib29">Keller et al., 2016</xref>; <xref ref-type="bibr" rid="bib30">Keller et al., 2018</xref>; <xref ref-type="bibr" rid="bib31">Keller et al., 2019</xref>). In mediation analysis of gene expression, trans-eQTL are conditioned on the expression of all other genes, including those at the locus to which the trans-eQTL map. If the genetic signal of the trans-eQTL decreases upon conditioning of a specific gene, that gene becomes a strong candidate as the driver of the trans-eQTL. We focused on the trans-eQTL for mt-Nd5 at the chr17 locus in heart, as this demonstrated the strongest genetic signal (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Mediation against <italic>Lrpprc</italic> resulted in a large drop in the LOD score for mt-Nd5 eQTL (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Similar results were observed for mediation of the other mt-eQTL to the heart hotspot (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). The allele effect patterns of the mt-Nd5 eQTL (<xref ref-type="fig" rid="fig4">Figure 4E</xref>) and that for the <italic>Lrpprc</italic> eQTL (<xref ref-type="fig" rid="fig4">Figure 4F</xref>) demonstrate the same, and concordant high and low haplotype subgroups. Taken together, our results in DO mice are consistent with that in the HMDP mouse cohort, and strongly suggest that LRPPRC functions as a positive driver of the mt-eQTL hotspot in heart.</p></sec><sec id="s2-8"><title>Chr7 locus affects CoQ metabolism</title><p>Finally, we analyzed the chr7 locus (26 proteins), which unlike the chr13 or chr17 loci, had no major representation of a single mitochondrial protein complex but was moderately enriched for ubiquinone biosynthesis (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Mapping the eigengene of the significantly associated mitochondrial proteins identified the peak SNP (rs32451909). We identified COQ7 as a strong candidate as it was the only protein exhibiting a <italic>cis</italic>-regulation at the locus in the region of linkage disequilibrium (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). COQ7 catalyzes a critical step in the biosynthesis of coenzyme Q (CoQ). Among several functions, CoQ participates in electron transport facilitating ATP synthesis. CoQ also has a clear role in heart failure (<xref ref-type="bibr" rid="bib68">Sharma et al., 2016</xref>). Phenotypically, we observed lower levels of both the eigengene and COQ7 with the GG allele (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). This was functionally translated into higher heart weight in strains containing GG allele in both sexes under DIO stress only (<xref ref-type="fig" rid="fig5">Figure 5D–F</xref>). We also observed that abundance levels of other COQ proteins were strongly correlated with COQ7 protein, thus demonstrating that they are co-regulated (<xref ref-type="fig" rid="fig5">Figure 5G–I</xref>). At least two of these proteins, COQ3 and COQ6, are associated with the chr7 locus (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). When we measured the CoQ levels in both the mitochondrial fractions and total heart lysates from DIO-stressed female HMDP strains (n=15 strains), we observed a significant upregulation in the levels of both CoQ9 and CoQ10 in the lysates from HMDP mice harboring the GG allele (<xref ref-type="fig" rid="fig5">Figure 5J</xref>). Taken together, we conclude that the chr7 locus controls CoQ metabolism <italic>via</italic> regulation of the COQ7 protein.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Chr7 locus affects CoQ metabolism <italic>via</italic> COQ7.</title><p>(<bold>A</bold>) Circos plot showing chr7 hotspot. Each line signifies a significant association between the genetic variants and the respective protein levels with candidate genes being highlighted. (<bold>B</bold>) Manhattan and regional plots of chr7 locus (turquoise module) eigengene, respectively. Red line signifies genome-wide significance threshold (p&lt;4.1E-06). The peak SNPs and the candidate genes are highlighted. Genotype distribution plots of (<bold>C</bold>) protein levels and eigengenes, and cardiac phenotypes from (<bold>D</bold>) ISO-induced HF model and (<bold>E</bold>) female and (<bold>F</bold>) male DIO model at peak SNP (rs32451909) associated with chr7 locus. Protein-by-protein correlation plots between heart COQ7 and (<bold>G</bold>) COQ3, (<bold>H</bold>) COQ6 and (<bold>I</bold>) COQ9 abundance levels. (<bold>J</bold>) Genotype distribution plots of CoQ9 or CoQ10 levels in both the mitochondrial fractions and total heart lysates from female DIO model at peak SNPs associated with chr7 (rs32451909) locus. Data are presented as (<bold>C–F and J</bold>) boxplots showing median and interquartile range with outliers shown as circles (n=68–72 strains for protein levels; n=92–95 strains for ISO-model; n=92–100 strains for DIO-model; n=15 strains for CoQ9 and CoQ10 levels). p Values were calculated using (<bold>A and B</bold>) FaST-LMM that uses Likelihood-Ratio test; (<bold>C–F and J</bold>) Unpaired two-tailed Student’s t test; (<bold>G–I</bold>) BicorAndPvalue function of the WGCNA R-package that uses Unpaired two-tailed Student’s t test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82619-fig5-v1.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>We have previously used systems genetics analyses in HMDP and discovered a central role for adipose mitochondrial function in the sex differences observed in cardiometabolic traits, including obesity, insulin resistance and plasma lipids (<xref ref-type="bibr" rid="bib52">Norheim et al., 2019</xref>; <xref ref-type="bibr" rid="bib12">Chella Krishnan et al., 2021</xref>), and liver mitochondrial function in non-alcoholic fatty liver disease (<xref ref-type="bibr" rid="bib10">Chella Krishnan et al., 2018</xref>). In the present study, an integrative proteomics approach was utilized in HMDP to investigate the effects of genetic regulation of mitochondrial pathways on heart function. Several conclusions have emerged. First, we identified three distinct and independent <italic>trans</italic>-regulating genetic loci, on chr13, chr17 and chr7, respectively. Second, our enrichment analyses suggested mechanisms perturbed by each of these loci. Thus, the chr13 locus was enriched for mitochondrial complex I, chr17 for mitoribosomes, and chr7 was enriched for ubiquinone biosynthesis. Third, our regional mapping identified NDUFS4, LRPPRC and COQ7 as candidate genes for chr13, chr17, and chr7 loci, respectively. Finally, we performed both experimental and statistical analyses to support their causal roles. Each of these points is discussed in detail below.</p><p><italic>Trans</italic>-acting human pQTLs, mostly using blood/plasma proteome (<xref ref-type="bibr" rid="bib81">Yao et al., 2018</xref>; <xref ref-type="bibr" rid="bib61">Ruffieux et al., 2020</xref>; <xref ref-type="bibr" rid="bib85">Zhong et al., 2020</xref>; <xref ref-type="bibr" rid="bib79">Yang et al., 2021</xref>; <xref ref-type="bibr" rid="bib18">Folkersen et al., 2020</xref>; <xref ref-type="bibr" rid="bib21">He et al., 2020</xref>), and <italic>trans</italic>-acting human eQTLs (<xref ref-type="bibr" rid="bib2">Aguet, 2017</xref>; <xref ref-type="bibr" rid="bib7">Brynedal et al., 2017</xref>; <xref ref-type="bibr" rid="bib80">Yao et al., 2017</xref>; <xref ref-type="bibr" rid="bib70">Small et al., 2018</xref>; <xref ref-type="bibr" rid="bib19">GTEx Consortium, 2020</xref>), have been reported, but exploring <italic>trans</italic>-regulatory landscapes in human studies is limited by sample size, tissue accessibility, and environmental factors. In the current study, mapping genetic loci controlling protein abundance levels in heart tissues from an inbred mouse population revealed that ~9% of available nuclear-encoded mitochondrial proteins (74/848) are significantly controlled (p&lt;1E-6) by three genetic loci, on chr13 (26 proteins), chr17 (22 proteins) and chr7 (26 proteins), respectively. Each of these three <italic>trans</italic> regulating hotspots were specific for the proteome, as they were not identified in our heart transcriptome. Interestingly, two of these hotspots independently controlled mitochondrial complex I, one at the mRNA (chr17 <italic>via</italic> LRPPRC/SLIRP) and the other at the protein level (chr13 <italic>via miR-27b</italic>/NDUFS4). Finally, the chr7 locus was found to control ubiquinone metabolism <italic>via</italic> COQ7 protein.</p><p>Mitochondrial complex I is the first and largest (~1 MDa) protein complex of the mitochondrial electron transport chain comprised of 45 subunits, seven encoded in the mtDNA (<xref ref-type="bibr" rid="bib87">Zhu et al., 2016</xref>; <xref ref-type="bibr" rid="bib17">Fiedorczuk et al., 2016</xref>; <xref ref-type="bibr" rid="bib22">Hirst, 2013</xref>). NDUFS4 is an 18 kDa accessory subunit that assembles the catalytic N-module (where NADH oxidation occurs) with the rest of the complex I. Mutations leading to the loss of NDUFS4 result in complex I deficiency (<xref ref-type="bibr" rid="bib87">Zhu et al., 2016</xref>; <xref ref-type="bibr" rid="bib71">Stroud et al., 2016</xref>; <xref ref-type="bibr" rid="bib20">Gu et al., 2016</xref>; <xref ref-type="bibr" rid="bib25">Kahlhöfer et al., 2017</xref>; <xref ref-type="bibr" rid="bib64">Scacco et al., 2003</xref>) and are involved in cardiomyopathies, both in protective (ischemia/reperfusion injury) and detrimental roles (pressure overload) (<xref ref-type="bibr" rid="bib13">Chouchani et al., 2014</xref>; <xref ref-type="bibr" rid="bib28">Karamanlidis et al., 2013</xref>; <xref ref-type="bibr" rid="bib84">Zhang et al., 2018</xref>). It was also reported that loss of NDUFS4 causes reduced complex I mediated ROS generation (ischemia/reperfusion injury) and increased protein acetylation (pressure overload), leading to their respective pathologies. Here, we demonstrate that heart-specific NDUFS4 KO mice have higher levels of NDUFAF2, which is reported to partly stabilize complex I in the absence of NDUFS4, although the resultant complex I is unstable and has reduced activity (<xref ref-type="bibr" rid="bib1">Adjobo-Hermans et al., 2020</xref>). Taken together, we report that natural variation in NDUFS4 protein levels affect other complex I proteins resulting in reduced complex I activity and cardiac hypertrophy. On the other hand, the role of <italic>miR-27b</italic> on heart function is unclear. Cardiac-specific overexpression of <italic>miR-27b</italic> has been reported to increase pressure overload-induced cardiac hypertrophy <italic>via</italic> PPARG (<xref ref-type="bibr" rid="bib75">Wang et al., 2012</xref>) but attenuated angiotensin II-induced atrial fibrosis <italic>via</italic> ALK5 (<xref ref-type="bibr" rid="bib78">Wang et al., 2018</xref>). Also, whole body knockout of <italic>miR-27b</italic> was found to attenuate pressure overload-induced cardiac hypertrophy <italic>via</italic> FGF1 (<xref ref-type="bibr" rid="bib41">Li et al., 2022</xref>), but this could be due to extracardiac effects mediated by <italic>miR-27b-3p</italic> such as adipocyte browning (<xref ref-type="bibr" rid="bib83">Yu et al., 2018</xref>; <xref ref-type="bibr" rid="bib72">Sun and Trajkovski, 2014</xref>; <xref ref-type="bibr" rid="bib33">Kong et al., 2015</xref>). Using 100 HMDP inbred strains of mice, here we found that cardiac <italic>miR-27b</italic> expression was inversely correlated with heart weights and that mature <italic>miR-27b-3p</italic> appears to have a protective role in reducing cardiac hypertrophy <italic>via</italic> increasing NDUFS4 protein levels.</p><p>Mitochondria are unique organelles having their own genome that encodes for 13 protein coding genes, which are essential subunits of complexes I, III, IV, and V. Nuclear-encoded LRPPRC protein working together with the SLIRP protein helps to enable mitochondrial mRNA translation <italic>via</italic> promoting its polyadenylation and stability (<xref ref-type="bibr" rid="bib69">Siira et al., 2017</xref>; <xref ref-type="bibr" rid="bib14">Chujo et al., 2012</xref>; <xref ref-type="bibr" rid="bib62">Ruzzenente et al., 2012</xref>). Loss-of-function mutations in LRPPRC causes Leigh syndrome, French-Canadian type that are associated with complex IV deficiency, impaired mitochondrial respiration and in some cases, neonatal cardiomyopathy, and congenital cardiac abnormalities (<xref ref-type="bibr" rid="bib46">Mootha et al., 2003</xref>; <xref ref-type="bibr" rid="bib53">Oláhová et al., 2015</xref>). Here, we show that natural genetic variations in a panel of inbred mouse strains at a chr17 locus (TT allele) result in higher protein levels of the LRPPRC/SLIRP complex as well as lower heart weights. This phenomenon is most likely mediated by increased expression levels of mitochondrial mRNA that coincide with reduced protein levels of mitoribosomes. We propose that since these mitochondrial mRNAs are protected by LRPPRC/SLIRP complex, fewer mitoribosomes are necessary for translation. Interestingly, although LRPPRC mutations are often associated with complex IV deficiency (<xref ref-type="bibr" rid="bib46">Mootha et al., 2003</xref>; <xref ref-type="bibr" rid="bib53">Oláhová et al., 2015</xref>), we observed that complex I mRNAs were also strongly regulated by the LRPPRC/SLIRP complex, in addition to complex IV mRNAs. Thus, further research on the bioenergetic consequences of LRPPRC/SLIRP loss-of-function mutations beyond complex IV deficiency are warranted.</p><p>Mitochondrial coenzyme Q, or ubiquinone or CoQ, is essential for mitochondrial electron transport chain function as it shuttles electrons from both complexes I and II to complex III. The enzyme COQ7 is responsible for catalyzing the penultimate step in CoQ biosynthesis. Here, we report that the chr7 locus (GG allele) is associated with reduced levels of COQ7 protein, which is in turn associated with increased heart weights. Interestingly, when we measured CoQ levels in these hearts, we found no differences in the mitochondrial fractions but an increase in both CoQ9 and CoQ10 levels in the lysates. Mice with a complete loss of <italic>Coq7</italic> expression have embryonic lethality (<xref ref-type="bibr" rid="bib49">Nakai et al., 2001</xref>) but survive for several months after a knockout is induced in the adult (<xref ref-type="bibr" rid="bib76">Wang et al., 2015</xref>). Interestingly, <italic>Coq7</italic> heterozygous knockout mice are long-lived but exhibit dysfunctional mitochondria (such as reduced respiration, reduced ATP levels and increased ROS generation) with no differences in CoQ levels despite significantly reduced COQ7 protein levels (<xref ref-type="bibr" rid="bib36">Lapointe and Hekimi, 2008</xref>; <xref ref-type="bibr" rid="bib37">Lapointe et al., 2009</xref>; <xref ref-type="bibr" rid="bib43">Liu et al., 2005</xref>). Furthermore, these <italic>Coq7</italic> heterozygous knockout mice were found to harbor a varying distribution of CoQ9 levels in their liver mitochondria with the outer membrane having increased CoQ9 while the inner membrane had reduced CoQ9 levels (<xref ref-type="bibr" rid="bib38">Lapointe et al., 2012</xref>). It was postulated that higher CoQ9 levels in the liver mitochondrial outer membrane may be a protective response to increased ROS levels generated in <italic>Coq7</italic> heterozygous knockout mice (<xref ref-type="bibr" rid="bib38">Lapointe et al., 2012</xref>). Thus, reduced COQ7 protein levels do not necessarily associate with reduced CoQ levels but have heterogeneous sub-mitochondrial and possibly subcellular CoQ distributions. Taken together, we propose that increased heart weights in mice harboring chr7 locus (GG allele) is a result of increased ROS generation caused by reduced COQ7 protein levels. Also, the increased CoQ levels in the heart lysates of these mice might be a protective response against the oxidative stress generated by reduced COQ7 protein in these mice. Further research is warranted in understanding the purported role of COQ7 in submitochondrial and subcellular CoQ heterogeneous distribution focusing on heart pathophysiology.</p><p>In conclusion, our unbiased systems genetics analyses identified three loci regulating mitochondrial function in the heart. None of these loci were observed when transcript levels were examined, providing justification for proteomic rather than transcriptomic studies. All three loci are associated with heart mass in two independent heart stress models and/or negatively correlated with known hypertrophic markers (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1j</xref>). Nevertheless, the percent change in heart mass between the three loci were only of modest value. However, both heart failure and hypertrophy being complex traits are influenced by a large number of genetic factors, each exerting a small to large effect. The resulting phenotypes are therefore a sum of all impacts. So, we believe it is important to characterize modest as well as large effects. In summary, our results provide mechanistic information about the roles of previously studied genes namely, NDUFS4, LRPPRC, and COQ7, in heart failure.</p></sec><sec id="s4" sec-type="methods"><title>Methods</title><sec id="s4-1"><title>Mice</title><p>All mice were purchased from The Jackson Laboratory and bred at UCLA according to approved institutional animal care and use committee (IACUC) protocols with daily monitoring. Both the ISO-induced HF (<xref ref-type="bibr" rid="bib59">Rau et al., 2015</xref>; <xref ref-type="bibr" rid="bib77">Wang et al., 2016</xref>; <xref ref-type="bibr" rid="bib60">Rau et al., 2017</xref>) and DIO (<xref ref-type="bibr" rid="bib55">Parks et al., 2013</xref>; <xref ref-type="bibr" rid="bib56">Parks et al., 2015</xref>) models were previously described in detail. Briefly, for ISO-induced HF model, 8–10 weeks of age female mice were administered with isoproterenol (30 mg per kg body weight per day, Sigma) for 21 days using ALZET osmotic minipumps, which were surgically implanted intraperitoneally. For DIO model, mice were fed ad libitum a chow diet (Ralston Purina Company) until 8 weeks of age and then placed ad libitum on a high-fat/high-sucrose (HF/HS) diet (Research Diets-D12266B, New Brunswick, NJ) with 16.8% kcal protein, 51.4% kcal carbohydrate, 31.8% kcal fat for an additional 8 weeks. For heart proteomic analysis, 8–12 weeks of age female HMDP mice (72 strains, n=2–3 mice; listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>) and 3–5 months old control and <italic>Ndufs4</italic>-cKO mice of both sex (n=5 each group) fed with chow diet ad libitum (Purina 5053, LabDiet) were used. All mice were maintained on a 14 hr light/10 hr dark cycle (light is on between 6 a.m. and 8 p.m.) at a temperature of 25 degrees and 30–70% humidity. On the day of the experiment, the mice were sacrificed after 4 hr fasting.</p></sec><sec id="s4-2"><title>Studies in Diversity Outbred mice</title><p>All experiments that used Diversity Outbred (DO) mice were conducted in the Biochemistry Department at the University of Wisconsin-Madison and approved by the university’s Animal Care and Use Committee as described previously (<xref ref-type="bibr" rid="bib30">Keller et al., 2018</xref>). Briefly, 4-week-old DO mice were purchased from the Jackson Labs (stock no. 009376) and placed on a Western-style diet high in fat and sucrose (17.3% protein, 34% carbohydrate, and 44.6% kcal fat) from Envigo Teklad (TD.08811). Mice were sacrificed at ~20 weeks of age, and tissues harvested and prepared for RNA-sequencing and expression quantitative trait loci (eQTL) analysis as previously detailed (<xref ref-type="bibr" rid="bib30">Keller et al., 2018</xref>). The expression of the 13 protein-coding mt-genes (mt-Nd1, mt-Nd2, mt-Nd3, mt-Nd4, mt-Nd4l, mt-Nd5, mt-Nd6, mt-Cytb, mt-Co1, mt-Co2, mt-Co3, and mt-Atp6, mt-Atp8) and two mt-ribosomal RNAs (mt-Rnr1, mt-Rnr2) were detected in each of the five tissues surveyed (heart, islet, skeletal muscle, adipose, and liver). Expression values for these mt-encoded transcripts in all tissues, and <italic>Lrpprc</italic> in heart, are provided in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>.</p></sec><sec id="s4-3"><title>Heart global proteomic analysis</title><p>Heart tissue from the HMDP, control and <italic>Ndufs4</italic>-cKO mice were lysed in 6 M guanidine HCL (Sigma; #G4505), 100 mM Tris pH 8.5 containing 10 mM tris(2-carboxyethyl)phosphine (Sigma; #75259) and 40 mM 2-chloroacetamide (Sigma; #22790) by tip-probe sonication. The lysate was heated at 95 °C for 5 min and centrifuged at 20,000 x <italic>g</italic> for 10 min at 4 °C. The supernatant was diluted 1:1 with water and precipitated overnight with five volumes of acetone at –20 °C. The lysate was centrifuged at 4000 x <italic>g</italic> for 5 min at 4 °C and the protein pellet was washed with 80% acetone. The lysate was centrifuged at 4000 x <italic>g</italic> for 5 min at 4 °C and the protein pellet was resuspended in Digestion Buffer (10% 2,2,2-Trifluoroethanol [Sigma; #96924] in 100 mM HEPEs pH 8.5). Protein was quantified with BCA (ThermoFisher Scientific) and normalized in Digestion Buffer to a final concentration of 2 µg/µl. Protein was digested with sequencing grade trypsin (Sigma; #T6567) and sequencing grade LysC (Wako; #129–02541) at a 1:50 enzyme:substrate ratio overnight at 37 °C with shaking at 2000 x rpm. Eight micrograms of peptide was directly labelled with 32 µg of 10-plex TMT (lot #QB211242) in 20 µl at a final concentration of 50% acetonitrile for 1.5 hr at room temperature. The reaction was de-acylated with a final concentration of 0.3% (w/v) hydroxylamine and quenched with a final concentration of 1% trifluoroacetic acid (TFA). Each 10-plex experiment contained nine different strains with a tenth reference label (131 isobaric label) made up of the same peptide digest from pooled mix of C57BL/6 J heart. Following labelling, the peptides from each of the 18 TMT 10-plex batches were pooled and purified directly by Styrene Divinylbenzene - Reversed-Phase Sulfonate (SDB-RPS) microcolumns, washed with 99% isopropanol containing 1% TFA and eluted with 80% acetonitrile containing 2% ammonium hydroxide followed by vacuum concentration. Peptides were resuspended in 2% acetonitrile containing 0.1% TFA and thirty micrograms of peptide was fractionated on an in-house fabricated 25 cm x 320 µm column packed with C18BEH particles (3 µm, Waters). Peptides were separated on a gradient of 0–30% acetonitrile containing 10 mM ammonium formate (pH 7.9) over 60 min at 6 µl/min using an Agilent 1260 HPLC and detection at 210 nm with a total of 48 fractions collected and concatenated down to 12 fractions.</p></sec><sec id="s4-4"><title>Mass spectrometry and data processing</title><p>Peptide fractions from heart were resuspended in 2% acetonitrile containing 0.1% TFA and analyzed on a Dionex ultra-high pressure liquid chromatography system coupled to an Orbitrap Lumos mass spectrometer. Briefly, peptides were separated on 40 cm x 75 µm column containing 1.9 µm C18AQ Reprosil particles on a linear gradient of 2–30% acetonitrile over 2 h. Electrospray ionization was performed at 2.3 kV with 40% RF lens and positively charged peptides detected via a full scan MS (350–1550 m/z, 1e6 AGC, 60 K resolution, 50ms injection time) followed data-dependent MS/MS analysis performed with CID of 35% normalized collision energy (NCE) (rapid scan rate, 2e4 AGC, 50ms injection time, 10ms activation time, 0.7 m/z isolation) of the top 10 most abundant peptides. Synchronous-precursor selection with MS3 (SPS-MS3) analysis was enabled with HCD of 60 NCE (100–500 m/z, 50 K resolution, 1e5 AGC, 105ms injection time) (<xref ref-type="bibr" rid="bib45">McAlister et al., 2014</xref>). Dynamic exclusion was enabled for 60 s. Data were processed with Proteome Discoverer v2.3 and searched against the Mouse UniProt database (November 2018) using SEQUEST (<xref ref-type="bibr" rid="bib16">Eng et al., 1994</xref>). The precursor MS tolerance were set to 20 ppm and the MS/MS tolerance was set to 0.8 Da with a maximum of 2 miss-cleavage. The peptides were searched with oxidation of methionine set as variable modification, and TMT tags on peptide N-terminus / lysine and carbamidomethylation of cysteine set as a fixed modification. All data was searched as a single batch and the peptide spectral matches (PSMs) of each database search filtered to 1% FDR using a target/decoy approach with Percolator (<xref ref-type="bibr" rid="bib26">Käll et al., 2007</xref>). The filtered PSMs from each database search were grouped and q-values generated at the peptide level with the Qvality algorithm (<xref ref-type="bibr" rid="bib27">Käll et al., 2009</xref>). Finally, the grouped peptide data was further filtered to 1% protein FDR using Protein Validator. Quantification was performed with the reporter ion quantification node for TMT quantification based on MS3 scans in Proteome Discoverer. TMT precision was set to 20 ppm and corrected for isotopic impurities. Only spectra with &lt;50% co-isolation interference were used for quantification with an average signal-to-noise filter of &gt;10. The data was filtered to retain Master proteins that were measured in at least 50 mice.</p></sec><sec id="s4-5"><title>HMDP heart mRNA and miRNA expression analysis</title><p>Using the miRNeasy Mini Kit (QIAGEN), total RNA was extracted from HMDP heart tissues. From this, global mRNA expression were analyzed as previously described (<xref ref-type="bibr" rid="bib9">Cao et al., 2022</xref>), while the QIAseq miRNA Library Kit (QIAGEN) was used to create miRNA libraries. These libraries were then sequenced using 1x50 HiSeq sequencing. Reads were mapped using hisat2 (version 2.0.6) and counted using htseq-count (version 0.13.5). Differential expression analysis was performed with DESeq2.</p></sec><sec id="s4-6"><title>Association mapping</title><p>Genotypes for the mouse strains were obtained using the Mouse Diversity Array (<xref ref-type="bibr" rid="bib5">Bennett et al., 2010</xref>). After filtering for quality or missing genotypes, about 200,000 remained. Genome-wide association for phenotypes and protein abundance levels was performed using Factored Spectrally Transformed Linear Mixed Models (FaST-LMM), which applies a linear mixed model to correct for population structure (<xref ref-type="bibr" rid="bib42">Lippert et al., 2011</xref>). A cutoff value for genome-wide significance was set at 4.1E-06, as determined previously (<xref ref-type="bibr" rid="bib5">Bennett et al., 2010</xref>).</p></sec><sec id="s4-7"><title>Cell culture and treatments</title><p>Following isolation, neonatal rat ventricular myocytes (NRVMs) were plated in DMEM containing 10% Fetal bovine serum (FBS) and 1% antibiotics overnight. The next day, NRVMs were changed to serum-free medium in the presence or absence of 100 µM phenylephrine (Sigma, Cat# P6126-10G). The cells were then transfected with miRNA control, mature <italic>miR-27b-5p</italic>, or <italic>miR-27b-3p</italic> mimics (Sigma) for 48 hr. The cell lysates were harvested for immunoblotting using primary antibodies against NDUFS4 (# sc-100567, Santa Cruz) and Actin (# 8457 S, Cell Signaling). Band densitometry was quantiﬁed using ImageJ Gel Plugin (NIH).</p><table-wrap id="inlinetable1" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Reagent</th><th align="left" valign="top">Mature sequence 5’ to 3’</th></tr></thead><tbody><tr><td align="left" valign="top">MISSION microRNA, Negative Control 1<break/>(miRNA control)</td><td align="left" valign="top">GGUUCGUACGUACACUGUUCA</td></tr><tr><td align="left" valign="top">MISSION microRNA - hsa-miR-27b*<break/>(miR-27b-5p)</td><td align="left" valign="top">AGAGCUUAGCUGAUUGGUGAAC</td></tr><tr><td align="left" valign="top">MISSION microRNA - hsa-miR-27b<break/>(miR-27b-3p)</td><td align="left" valign="top">UUCACAGUGGCUAAGUUCUGC</td></tr></tbody></table></table-wrap></sec><sec id="s4-8"><title>Mitochondria isolation from frozen hearts</title><p>Twenty mg of frozen hearts were thawed in 1.4 mL of ice-cold isolation buffer (70 mM sucrose, 220 mM mannitol, 1 mM EGTA, 2 mM HEPES, pH 7.4 containing protease inhibitors). Hearts were mechanically homogenized with 20 strokes of a Dounce homogenizer at 4 °C. Homogenates were centrifuged at 1000 <italic>g</italic> for 10 min at 4ﹾC. Supernatant was collected (300 µL were reserved as whole lysate) and centrifuged at 10,000 <italic>g</italic> for 10 min at 4°C to obtain a pellet containing the mitochondria. Mitochondrial pellet was re-suspended in 1 mL of isolation buffer and re-centrifuged at 10,000 <italic>g</italic> for 10 min at 4°C. The mitochondrial pellet was finally re-suspended in 200 µL of isolation buffer and protein concentration determined using the BCA assay.</p></sec><sec id="s4-9"><title>CoQ extraction from whole lysate and mitochondrial enriched fractions</title><p>CoQ extraction, detection and analysis was performed as described previously (<xref ref-type="bibr" rid="bib8">Burger et al., 2020</xref>). Briefly, 15 µg protein from mitochondrial fractions or 200 µg protein from total lysate were aliquoted into 2 mL Eppendorf tubes and volumes adjusted to 100 µL for mitochondrial fractions or 200 µL for whole lysates, and samples were kept on ice for the entire process. 20 µL of 0.1 ng/mL CoQ8 (2 ng total; Avanti Polar Lipids) were added to each sample as an internal standard. To protein aliquots ice-cold 250 µL acidified methanol (0.1% HCl in MeOH) were added to each sample, followed by 300 µL hexane and samples were thoroughly mixed by vertexing. Hexane and MeOH/water layers were separated by centrifugation at 15,000 <italic>g</italic> for 5 min at 4°C. The upper layer of hexane was collected and transferred to clean 2 mL Eppendorf tubes and completely dried in a GeneVac vacuum centrifuge, on a low BP point method for 40 min (20 min pre-final stage and 20 min final stage). Samples were reconstituted in 100 µL ethanol before analysis of CoQ levels by LC-MS.</p></sec><sec id="s4-10"><title>LC-MS analysis of CoQ</title><p>CoQ8, 9 and 10 levels were analyzed using a TSQ Altis triple quadrupole mass spectrometer (ThermoFisher) coupled to a Vanquish LC system (ThermoFisher). Fifteen µL of sample was injected and separated on a 2.6 μm Kinetex XB-C18 100 A column (50×2.10 mm; Phenomenex) at 45°C. Mobile Phase A consisted of 2.5 mM ammonium formate in 95% MeOH, 5% IPA and Mobile Phase B consisted of 2.4 mm ammonium formate in 100% IPA. A gradient method over 5 min was used with an initial concentration of 0% B held for 1 min before increased to 45% B over 1 min and held for 1 min, before decreasing back to 0% B over 0.5 min and column re-equilibrated over 1.5 min. Eluent was then directed into the QQQ with the following settings: source voltage = 3500 V; sheath gas 2; aux gas 2; transfer capillary temperature = 350 ﹾC. Ammonium adducts of each of the analytes were detected by SRM with Q1 and Q3 resolution set to 0.7 FWHM with the following parameters: [CoQ8 +NH4]<sup>+</sup>, <italic>m/</italic>z 744.9 → 197.1 with collision energy 32.76; [CoQ9 +NH4]<sup>+</sup>, <italic>m/</italic>z 812.9 → 197.1 with collision energy 32.76; [CoQ9H<sub>2</sub>+NH4]<sup>+</sup>, <italic>m/</italic>z 814.9 → 197.1 with collision energy 36.4; [CoQ10 +NH4]<sup>+</sup>, <italic>m/</italic>z 880.9 → 197.1 with collision energy 32.76; and [CoQ10H<sub>2</sub>+NH4]<sup>+</sup>, <italic>m/</italic>z 882.9 → 197.1 with collision energy 36.4. CoQ9 and CoQ10 were quantified in samples against a standard curve (0–1,000 nM) and normalized to spiked in CoQ8 levels (20 ng/mL) in each sample and standard. No CoQ9H<sub>2</sub> and CoQ10H<sub>2</sub> were detected in any of the samples, though some bleed through into these channels was detected for the oxidized analytes, though these are resolved from the reduced standard peaks (as reported previously).</p></sec><sec id="s4-11"><title>Statistical analysis</title><p>Statistical analyses were performed using Prism v9.4.0 (GraphPad Software, Inc, La Jolla, CA, USA). Errors bars plotted on graphs are presented as the mean ± SEM unless reported otherwise. The critical significance value (α) was set at 0.05, and if the p values were less than α, we reported that the observed differences were statistically significant. Correlations were calculated using biweight midcorrelation using the bicorAndPvalue function of the WGCNA package (<xref ref-type="bibr" rid="bib35">Langfelder and Horvath, 2008</xref>).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>Senior Editor, eLife; Senior Editor for the Systems Genetics Special Issue (DEJ had no involvement in the decision making for this submission)</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Visualization</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con7"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con8"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con9"><p>Formal analysis, Investigation, Visualization</p></fn><fn fn-type="con" id="con10"><p>Formal analysis, Investigation, Visualization</p></fn><fn fn-type="con" id="con11"><p>Formal analysis, Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con12"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con13"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con14"><p>Resources, Supervision, Funding acquisition</p></fn><fn fn-type="con" id="con15"><p>Resources, Supervision, Funding acquisition</p></fn><fn fn-type="con" id="con16"><p>Formal analysis, Investigation, Visualization</p></fn><fn fn-type="con" id="con17"><p>Resources, Supervision, Funding acquisition</p></fn><fn fn-type="con" id="con18"><p>Resources, Supervision, Funding acquisition</p></fn><fn fn-type="con" id="con19"><p>Resources, Supervision, Funding acquisition</p></fn><fn fn-type="con" id="con20"><p>Formal analysis, Investigation, Visualization, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con21"><p>Resources, Supervision, Funding acquisition, Writing – review and editing</p></fn><fn fn-type="con" id="con22"><p>Conceptualization, Resources, Supervision, Funding acquisition, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Mice.All mice were purchased from The Jackson Laboratory and bred at UCLA according to approved institutional animal care and use committee (IACUC) protocols with daily monitoring. All mice were maintained on a 14 h light/10 h dark cycle (light is on between 6 a.m. and 8 p.m.) at a temperature of 25 degrees and 30-70% humidity. On the day of the experiment, the mice were sacrificed after 4-hour fasting.Studies in Diversity Outbred mice.All experiments that used Diversity Outbred (DO) mice were conducted in the Biochemistry Department at the University of Wisconsin-Madison and approved by the university's Animal Care and Use Committee. Briefly, 4-week-old DO mice were purchased from the Jackson Labs (stock no. 009376) and placed on a Western-style diet high in fat and sucrose (17.3% protein, 34% carbohydrate, and 44.6% kcal fat) from Envigo Teklad (TD.08811).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Supplementary tables.</title><p>(<bold>a</bold>) List of HMDP strains used for proteomic analyses and their respective genotypes at the three loci. (<bold>b</bold>) Five modules of WGCNA and their corresponding proteins. (<bold>c</bold>) List of proteins associated with chr13 locus listed in <xref ref-type="fig" rid="fig2">Figure 2A</xref>. The associated P values between the respective proteins and chr13 locus eigengene pSNP are listed. (<bold>d</bold>) List of proteins associated with chr17 locus listed in <xref ref-type="fig" rid="fig3">Figure 3A</xref>. The associated P values between the respective proteins and chr17 locus eigengene pSNP are listed. (<bold>e</bold>) List of proteins associated with chr7 locus listed in <xref ref-type="fig" rid="fig4">Figure 4A</xref>. The associated P values between the respective proteins and chr7 locus eigengene pSNP are listed. (<bold>f</bold>) Scoring of miRNA targeting <italic>Ndufs4</italic> by nine algorithms and one dataset of experimental validation. (<bold>g</bold>) List of differentially abundant proteins between the control and <italic>Ndufs4</italic>-cKO groups, and their P values shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>. Only proteins that passed the signifcant cut-off (abs[log2FC]&gt;1 and Padj &lt;0.001) are listed. Proteins overlapping chr13 locus are shown in blue font. (<bold>h</bold>) List of 157 mt-eQTL (LOD &gt;6) across five tissues in the DO mice as shown in <xref ref-type="fig" rid="fig4">Figure 4A</xref>. (<bold>i</bold>) SNP association profile for mt-Nd5 in heart as shown in <xref ref-type="fig" rid="fig4">Figure 4C</xref>. (<bold>j</bold>) Protein-protein correlations between the three candidates and known hypertrophic markers. The bicor P values between the respective markers and each locus candidate gene are listed.</p></caption><media xlink:href="elife-82619-supp1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Expression values for mt-encoded transcripts and/or <italic>Lrpprc</italic> in skeletal muscle (2 a), adipose (2b), islets (2 c), liver (2d) and heart (2e).</title></caption><media xlink:href="elife-82619-supp2-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-82619-transrepform1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All sequencing raw data can be accessed at the Gene Expression Omnibus under accession GSE194198 (HF/HS heart HMDP RNA-seq data) and GSE207142 (HF/HS heart HMDP miRNA-seq data). The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE <xref ref-type="bibr" rid="bib57">Perez-Riverol et al., 2022</xref> partner repository with the dataset identifiers PXD036398 (HMDP hearts) and PXD036399 (NDUFS4 KO hearts).</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Lusis</surname><given-names>AJ</given-names></name><name><surname>Chella Krishnan</surname><given-names>K</given-names></name><name><surname>Kaczor-Urbanowicz</surname><given-names>KE</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Small RNA sequencing of hearts from female mice on high fat diet, from 85 strains</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE207142">GSE207142</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Lusis</surname><given-names>AJ</given-names></name><name><surname>Chella Krishnan</surname><given-names>K</given-names></name><name><surname>Parker</surname><given-names>BL</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>HMDP hearts</data-title><source>ProteomeXchange</source><pub-id pub-id-type="accession" xlink:href="https://proteomecentral.proteomexchange.org/cgi/GetDataset?ID=PXD036398">PXD036398</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset3"><person-group person-group-type="author"><name><surname>Lusis</surname><given-names>AJ</given-names></name><name><surname>Chella Krishnan</surname><given-names>K</given-names></name><name><surname>Parker</surname><given-names>BL</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>NDUFS4 KO hearts</data-title><source>ProteomeXchange</source><pub-id pub-id-type="accession" xlink:href="https://proteomecentral.proteomexchange.org/cgi/GetDataset?ID=PXD036399">PXD036399</pub-id></element-citation></p><p>The following previously published dataset was used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset4"><person-group person-group-type="author"><name><surname>Lusis</surname><given-names>AJ</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Heart profiling in HMDP (high-fat/high-sucrose diet)</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE194198">GSE194198</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This work was supported by NIH grants DK120342, HL148577 and HL147883 (AJL) and DOD grant W81XWH2110115 (AJL); R00DK120875 (KCK); R00HL138193 (MMS); R01DK101573, R01DK102948, and RC2DK125961 (ADA); Wisconsin Alumni Research Foundation (MPK); National Health and Medical Research Council of Australia (NHMRC) grants and fellowships (DEJ and BLP); Systems Biology Association fellowship, Foundation Sorbonne fellowship, French Minister, and Master BIP (EJEH). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adjobo-Hermans</surname><given-names>MJW</given-names></name><name><surname>de Haas</surname><given-names>R</given-names></name><name><surname>Willems</surname><given-names>P</given-names></name><name><surname>Wojtala</surname><given-names>A</given-names></name><name><surname>van Emst-de Vries</surname><given-names>SE</given-names></name><name><surname>Wagenaars</surname><given-names>JA</given-names></name><name><surname>van den Brand</surname><given-names>M</given-names></name><name><surname>Rodenburg</surname><given-names>RJ</given-names></name><name><surname>Smeitink</surname><given-names>JAM</given-names></name><name><surname>Nijtmans</surname><given-names>LG</given-names></name><name><surname>Sazanov</surname><given-names>LA</given-names></name><name><surname>Wieckowski</surname><given-names>MR</given-names></name><name><surname>Koopman</surname><given-names>WJH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Ndufs4 deletion triggers loss of Ndufa12 in Ndufs4(-/-) mice and Leigh syndrome patients: A stabilizing role for Ndufaf2</article-title><source>Biochimica et Biophysica Acta. Bioenergetics</source><volume>1861</volume><elocation-id>148213</elocation-id><pub-id pub-id-type="doi">10.1016/j.bbabio.2020.148213</pub-id><pub-id pub-id-type="pmid">32335026</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguet</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Genetic effects on gene expression across human tissues</article-title><source>Nature</source><volume>550</volume><fpage>204</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1038/nature24277</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>AT</given-names></name><name><surname>Boehme</surname><given-names>L</given-names></name><name><surname>Carbajosa</surname><given-names>G</given-names></name><name><surname>Seitan</surname><given-names>VC</given-names></name><name><surname>Small</surname><given-names>KS</given-names></name><name><surname>Hodgkinson</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Nuclear genetic regulation of the human mitochondrial transcriptome</article-title><source>eLife</source><volume>8</volume><elocation-id>e41927</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.41927</pub-id><pub-id pub-id-type="pmid">30775970</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Begriche</surname><given-names>K</given-names></name><name><surname>Igoudjil</surname><given-names>A</given-names></name><name><surname>Pessayre</surname><given-names>D</given-names></name><name><surname>Fromenty</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it</article-title><source>Mitochondrion</source><volume>6</volume><fpage>1</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.mito.2005.10.004</pub-id><pub-id pub-id-type="pmid">16406828</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>BJ</given-names></name><name><surname>Farber</surname><given-names>CR</given-names></name><name><surname>Orozco</surname><given-names>L</given-names></name><name><surname>Kang</surname><given-names>HM</given-names></name><name><surname>Ghazalpour</surname><given-names>A</given-names></name><name><surname>Siemers</surname><given-names>N</given-names></name><name><surname>Neubauer</surname><given-names>M</given-names></name><name><surname>Neuhaus</surname><given-names>I</given-names></name><name><surname>Yordanova</surname><given-names>R</given-names></name><name><surname>Guan</surname><given-names>B</given-names></name><name><surname>Truong</surname><given-names>A</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>He</surname><given-names>A</given-names></name><name><surname>Kayne</surname><given-names>P</given-names></name><name><surname>Gargalovic</surname><given-names>P</given-names></name><name><surname>Kirchgessner</surname><given-names>T</given-names></name><name><surname>Pan</surname><given-names>C</given-names></name><name><surname>Castellani</surname><given-names>LW</given-names></name><name><surname>Kostem</surname><given-names>E</given-names></name><name><surname>Furlotte</surname><given-names>N</given-names></name><name><surname>Drake</surname><given-names>TA</given-names></name><name><surname>Eskin</surname><given-names>E</given-names></name><name><surname>Lusis</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A high-resolution Association mapping panel for the dissection of complex traits in mice</article-title><source>Genome Research</source><volume>20</volume><fpage>281</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1101/gr.099234.109</pub-id><pub-id pub-id-type="pmid">20054062</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>DA</given-names></name><name><surname>Perry</surname><given-names>JB</given-names></name><name><surname>Allen</surname><given-names>ME</given-names></name><name><surname>Sabbah</surname><given-names>HN</given-names></name><name><surname>Stauffer</surname><given-names>BL</given-names></name><name><surname>Shaikh</surname><given-names>SR</given-names></name><name><surname>Cleland</surname><given-names>JGF</given-names></name><name><surname>Colucci</surname><given-names>WS</given-names></name><name><surname>Butler</surname><given-names>J</given-names></name><name><surname>Voors</surname><given-names>AA</given-names></name><name><surname>Anker</surname><given-names>SD</given-names></name><name><surname>Pitt</surname><given-names>B</given-names></name><name><surname>Pieske</surname><given-names>B</given-names></name><name><surname>Filippatos</surname><given-names>G</given-names></name><name><surname>Greene</surname><given-names>SJ</given-names></name><name><surname>Gheorghiade</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Expert consensus document: mitochondrial function as a therapeutic target in heart failure</article-title><source>Nature Reviews Cardiology</source><volume>14</volume><fpage>238</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1038/nrcardio.2016.203</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brynedal</surname><given-names>B</given-names></name><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>Raj</surname><given-names>T</given-names></name><name><surname>Bjornson</surname><given-names>R</given-names></name><name><surname>Stranger</surname><given-names>BE</given-names></name><name><surname>Neale</surname><given-names>BM</given-names></name><name><surname>Voight</surname><given-names>BF</given-names></name><name><surname>Cotsapas</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Large-scale Trans-eQTLs affect hundreds of transcripts and mediate patterns of transcriptional Co-regulation</article-title><source>American Journal of Human Genetics</source><volume>100</volume><fpage>581</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2017.02.004</pub-id><pub-id pub-id-type="pmid">28285767</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burger</surname><given-names>N</given-names></name><name><surname>Logan</surname><given-names>A</given-names></name><name><surname>Prime</surname><given-names>TA</given-names></name><name><surname>Mottahedin</surname><given-names>A</given-names></name><name><surname>Caldwell</surname><given-names>ST</given-names></name><name><surname>Krieg</surname><given-names>T</given-names></name><name><surname>Hartley</surname><given-names>RC</given-names></name><name><surname>James</surname><given-names>AM</given-names></name><name><surname>Murphy</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A sensitive mass spectrometric assay for mitochondrial Coq pool redox state in vivo</article-title><source>Free Radical Biology &amp; Medicine</source><volume>147</volume><fpage>37</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2019.11.028</pub-id><pub-id pub-id-type="pmid">31811922</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Vergnes</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>YC</given-names></name><name><surname>Pan</surname><given-names>C</given-names></name><name><surname>Chella Krishnan</surname><given-names>K</given-names></name><name><surname>Moore</surname><given-names>TM</given-names></name><name><surname>Rosa-Garrido</surname><given-names>M</given-names></name><name><surname>Kimball</surname><given-names>TH</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Charugundla</surname><given-names>S</given-names></name><name><surname>Rau</surname><given-names>CD</given-names></name><name><surname>Seldin</surname><given-names>MM</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Vondriska</surname><given-names>TM</given-names></name><name><surname>Reue</surname><given-names>K</given-names></name><name><surname>Lusis</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Sex differences in heart mitochondria regulate diastolic dysfunction</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>3850</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-31544-5</pub-id><pub-id pub-id-type="pmid">35787630</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chella Krishnan</surname><given-names>K</given-names></name><name><surname>Kurt</surname><given-names>Z</given-names></name><name><surname>Barrere-Cain</surname><given-names>R</given-names></name><name><surname>Sabir</surname><given-names>S</given-names></name><name><surname>Das</surname><given-names>A</given-names></name><name><surname>Floyd</surname><given-names>R</given-names></name><name><surname>Vergnes</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Che</surname><given-names>N</given-names></name><name><surname>Charugundla</surname><given-names>S</given-names></name><name><surname>Qi</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Meng</surname><given-names>Y</given-names></name><name><surname>Pan</surname><given-names>C</given-names></name><name><surname>Seldin</surname><given-names>MM</given-names></name><name><surname>Norheim</surname><given-names>F</given-names></name><name><surname>Hui</surname><given-names>S</given-names></name><name><surname>Reue</surname><given-names>K</given-names></name><name><surname>Lusis</surname><given-names>AJ</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Integration of multi-Omics data from mouse diversity panel highlights mitochondrial dysfunction in non-alcoholic fatty liver disease</article-title><source>Cell Systems</source><volume>6</volume><fpage>103</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1016/j.cels.2017.12.006</pub-id><pub-id pub-id-type="pmid">29361464</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chella Krishnan</surname><given-names>K</given-names></name><name><surname>Sabir</surname><given-names>S</given-names></name><name><surname>Shum</surname><given-names>M</given-names></name><name><surname>Meng</surname><given-names>Y</given-names></name><name><surname>Acín-Pérez</surname><given-names>R</given-names></name><name><surname>Lang</surname><given-names>JM</given-names></name><name><surname>Floyd</surname><given-names>RR</given-names></name><name><surname>Vergnes</surname><given-names>L</given-names></name><name><surname>Seldin</surname><given-names>MM</given-names></name><name><surname>Fuqua</surname><given-names>BK</given-names></name><name><surname>Jayasekera</surname><given-names>DW</given-names></name><name><surname>Nand</surname><given-names>SK</given-names></name><name><surname>Anum</surname><given-names>DC</given-names></name><name><surname>Pan</surname><given-names>C</given-names></name><name><surname>Stiles</surname><given-names>L</given-names></name><name><surname>Péterfy</surname><given-names>M</given-names></name><name><surname>Reue</surname><given-names>K</given-names></name><name><surname>Liesa</surname><given-names>M</given-names></name><name><surname>Lusis</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Sex-specific metabolic functions of Adipose Lipocalin-2</article-title><source>Molecular Metabolism</source><volume>30</volume><fpage>30</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.molmet.2019.09.009</pub-id><pub-id pub-id-type="pmid">31767179</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chella Krishnan</surname><given-names>K</given-names></name><name><surname>Vergnes</surname><given-names>L</given-names></name><name><surname>Acín-Pérez</surname><given-names>R</given-names></name><name><surname>Stiles</surname><given-names>L</given-names></name><name><surname>Shum</surname><given-names>M</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Mouisel</surname><given-names>E</given-names></name><name><surname>Pan</surname><given-names>C</given-names></name><name><surname>Moore</surname><given-names>TM</given-names></name><name><surname>Péterfy</surname><given-names>M</given-names></name><name><surname>Romanoski</surname><given-names>CE</given-names></name><name><surname>Reue</surname><given-names>K</given-names></name><name><surname>Björkegren</surname><given-names>JLM</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name><name><surname>Liesa</surname><given-names>M</given-names></name><name><surname>Lusis</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Sex-specific genetic regulation of Adipose mitochondria and metabolic syndrome by Ndufv2</article-title><source>Nature Metabolism</source><volume>3</volume><fpage>1552</fpage><lpage>1568</lpage><pub-id pub-id-type="doi">10.1038/s42255-021-00481-w</pub-id><pub-id pub-id-type="pmid">34697471</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chouchani</surname><given-names>ET</given-names></name><name><surname>Methner</surname><given-names>C</given-names></name><name><surname>Buonincontri</surname><given-names>G</given-names></name><name><surname>Hu</surname><given-names>C-H</given-names></name><name><surname>Logan</surname><given-names>A</given-names></name><name><surname>Sawiak</surname><given-names>SJ</given-names></name><name><surname>Murphy</surname><given-names>MP</given-names></name><name><surname>Krieg</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Complex I deficiency due to selective loss of Ndufs4 in the mouse heart results in severe hypertrophic cardiomyopathy</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e94157</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0094157</pub-id><pub-id pub-id-type="pmid">24705922</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chujo</surname><given-names>T</given-names></name><name><surname>Ohira</surname><given-names>T</given-names></name><name><surname>Sakaguchi</surname><given-names>Y</given-names></name><name><surname>Goshima</surname><given-names>N</given-names></name><name><surname>Nomura</surname><given-names>N</given-names></name><name><surname>Nagao</surname><given-names>A</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>LRPPRC/SLIRP suppresses Pnpase-mediated mRNA decay and promotes Polyadenylation in human mitochondria</article-title><source>Nucleic Acids Research</source><volume>40</volume><fpage>8033</fpage><lpage>8047</lpage><pub-id pub-id-type="doi">10.1093/nar/gks506</pub-id><pub-id pub-id-type="pmid">22661577</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Civelek</surname><given-names>M</given-names></name><name><surname>Lusis</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Systems Genetics approaches to understand complex traits</article-title><source>Nature Reviews. Genetics</source><volume>15</volume><fpage>34</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1038/nrg3575</pub-id><pub-id pub-id-type="pmid">24296534</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eng</surname><given-names>JK</given-names></name><name><surname>McCormack</surname><given-names>AL</given-names></name><name><surname>Yates</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>An approach to correlate Tandem mass spectral data of peptides with amino acid sequences in a protein database</article-title><source>Journal of the American Society for Mass Spectrometry</source><volume>5</volume><fpage>976</fpage><lpage>989</lpage><pub-id pub-id-type="doi">10.1016/1044-0305(94)80016-2</pub-id><pub-id pub-id-type="pmid">24226387</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiedorczuk</surname><given-names>K</given-names></name><name><surname>Letts</surname><given-names>JA</given-names></name><name><surname>Degliesposti</surname><given-names>G</given-names></name><name><surname>Kaszuba</surname><given-names>K</given-names></name><name><surname>Skehel</surname><given-names>M</given-names></name><name><surname>Sazanov</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Atomic structure of the entire mammalian mitochondrial complex I</article-title><source>Nature</source><volume>538</volume><fpage>406</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1038/nature19794</pub-id><pub-id pub-id-type="pmid">27595392</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Folkersen</surname><given-names>L</given-names></name><name><surname>Gustafsson</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Hansen</surname><given-names>DH</given-names></name><name><surname>Hedman</surname><given-names>ÅK</given-names></name><name><surname>Schork</surname><given-names>A</given-names></name><name><surname>Page</surname><given-names>K</given-names></name><name><surname>Zhernakova</surname><given-names>DV</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Peters</surname><given-names>J</given-names></name><name><surname>Eriksson</surname><given-names>N</given-names></name><name><surname>Bergen</surname><given-names>SE</given-names></name><name><surname>Boutin</surname><given-names>TS</given-names></name><name><surname>Bretherick</surname><given-names>AD</given-names></name><name><surname>Enroth</surname><given-names>S</given-names></name><name><surname>Kalnapenkis</surname><given-names>A</given-names></name><name><surname>Gådin</surname><given-names>JR</given-names></name><name><surname>Suur</surname><given-names>BE</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Matic</surname><given-names>L</given-names></name><name><surname>Gale</surname><given-names>JD</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Quazi</surname><given-names>A</given-names></name><name><surname>Ala-Korpela</surname><given-names>M</given-names></name><name><surname>Choi</surname><given-names>SH</given-names></name><name><surname>Claringbould</surname><given-names>A</given-names></name><name><surname>Danesh</surname><given-names>J</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>de Masi</surname><given-names>F</given-names></name><name><surname>Elmståhl</surname><given-names>S</given-names></name><name><surname>Engström</surname><given-names>G</given-names></name><name><surname>Fauman</surname><given-names>E</given-names></name><name><surname>Fernandez</surname><given-names>C</given-names></name><name><surname>Franke</surname><given-names>L</given-names></name><name><surname>Franks</surname><given-names>PW</given-names></name><name><surname>Giedraitis</surname><given-names>V</given-names></name><name><surname>Haley</surname><given-names>C</given-names></name><name><surname>Hamsten</surname><given-names>A</given-names></name><name><surname>Ingason</surname><given-names>A</given-names></name><name><surname>Johansson</surname><given-names>Å</given-names></name><name><surname>Joshi</surname><given-names>PK</given-names></name><name><surname>Lind</surname><given-names>L</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Lubitz</surname><given-names>S</given-names></name><name><surname>Palmer</surname><given-names>T</given-names></name><name><surname>Macdonald-Dunlop</surname><given-names>E</given-names></name><name><surname>Magnusson</surname><given-names>M</given-names></name><name><surname>Melander</surname><given-names>O</given-names></name><name><surname>Michaelsson</surname><given-names>K</given-names></name><name><surname>Morris</surname><given-names>AP</given-names></name><name><surname>Mägi</surname><given-names>R</given-names></name><name><surname>Nagle</surname><given-names>MW</given-names></name><name><surname>Nilsson</surname><given-names>PM</given-names></name><name><surname>Nilsson</surname><given-names>J</given-names></name><name><surname>Orho-Melander</surname><given-names>M</given-names></name><name><surname>Polasek</surname><given-names>O</given-names></name><name><surname>Prins</surname><given-names>B</given-names></name><name><surname>Pålsson</surname><given-names>E</given-names></name><name><surname>Qi</surname><given-names>T</given-names></name><name><surname>Sjögren</surname><given-names>M</given-names></name><name><surname>Sundström</surname><given-names>J</given-names></name><name><surname>Surendran</surname><given-names>P</given-names></name><name><surname>Võsa</surname><given-names>U</given-names></name><name><surname>Werge</surname><given-names>T</given-names></name><name><surname>Wernersson</surname><given-names>R</given-names></name><name><surname>Westra</surname><given-names>H-J</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Zhernakova</surname><given-names>A</given-names></name><name><surname>Ärnlöv</surname><given-names>J</given-names></name><name><surname>Fu</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>JG</given-names></name><name><surname>Esko</surname><given-names>T</given-names></name><name><surname>Hayward</surname><given-names>C</given-names></name><name><surname>Gyllensten</surname><given-names>U</given-names></name><name><surname>Landen</surname><given-names>M</given-names></name><name><surname>Siegbahn</surname><given-names>A</given-names></name><name><surname>Wilson</surname><given-names>JF</given-names></name><name><surname>Wallentin</surname><given-names>L</given-names></name><name><surname>Butterworth</surname><given-names>AS</given-names></name><name><surname>Holmes</surname><given-names>MV</given-names></name><name><surname>Ingelsson</surname><given-names>E</given-names></name><name><surname>Mälarstig</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals</article-title><source>Nature Metabolism</source><volume>2</volume><fpage>1135</fpage><lpage>1148</lpage><pub-id pub-id-type="doi">10.1038/s42255-020-00287-2</pub-id><pub-id pub-id-type="pmid">33067605</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>GTEx Consortium</collab></person-group><year iso-8601-date="2020">2020</year><article-title>The Gtex consortium Atlas of genetic regulatory effects across human tissues</article-title><source>Science</source><volume>369</volume><fpage>1318</fpage><lpage>1330</lpage><pub-id pub-id-type="doi">10.1126/science.aaz1776</pub-id><pub-id pub-id-type="pmid">32913098</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Guo</surname><given-names>R</given-names></name><name><surname>Yan</surname><given-names>K</given-names></name><name><surname>Lei</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>N</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The architecture of the mammalian Respirasome</article-title><source>Nature</source><volume>537</volume><fpage>639</fpage><lpage>643</lpage><pub-id pub-id-type="doi">10.1038/nature19359</pub-id><pub-id pub-id-type="pmid">27654917</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>B</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Zhu</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Genome-wide pQTL analysis of protein expression regulatory networks in the human liver</article-title><source>BMC Biology</source><volume>18</volume><elocation-id>97</elocation-id><pub-id pub-id-type="doi">10.1186/s12915-020-00830-3</pub-id><pub-id pub-id-type="pmid">32778093</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirst</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mitochondrial complex I</article-title><source>Annual Review of Biochemistry</source><volume>82</volume><fpage>551</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1146/annurev-biochem-070511-103700</pub-id><pub-id pub-id-type="pmid">23527692</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>DW</given-names></name><name><surname>Sherman</surname><given-names>BT</given-names></name><name><surname>Lempicki</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Systematic and integrative analysis of large Gene lists using DAVID Bioinformatics resources</article-title><source>Nature Protocols</source><volume>4</volume><fpage>44</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1038/nprot.2008.211</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>ST</given-names></name><name><surname>Kurt</surname><given-names>Z</given-names></name><name><surname>Tuominen</surname><given-names>I</given-names></name><name><surname>Norheim</surname><given-names>F</given-names></name><name><surname>Davis</surname><given-names>RC</given-names></name><name><surname>Pan</surname><given-names>C</given-names></name><name><surname>Dirks</surname><given-names>DL</given-names></name><name><surname>Magyar</surname><given-names>CE</given-names></name><name><surname>French</surname><given-names>SW</given-names></name><name><surname>Chella Krishnan</surname><given-names>K</given-names></name><name><surname>Sabir</surname><given-names>S</given-names></name><name><surname>Campos-Pérez</surname><given-names>F</given-names></name><name><surname>Méndez-Sánchez</surname><given-names>N</given-names></name><name><surname>Macías-Kauffer</surname><given-names>L</given-names></name><name><surname>León-Mimila</surname><given-names>P</given-names></name><name><surname>Canizales-Quinteros</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Beaven</surname><given-names>SW</given-names></name><name><surname>Huertas-Vazquez</surname><given-names>A</given-names></name><name><surname>Lusis</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The genetic architecture of diet-induced hepatic fibrosis in mice</article-title><source>Hepatology</source><volume>68</volume><fpage>2182</fpage><lpage>2196</lpage><pub-id pub-id-type="doi">10.1002/hep.30113</pub-id><pub-id pub-id-type="pmid">29907965</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahlhöfer</surname><given-names>F</given-names></name><name><surname>Kmita</surname><given-names>K</given-names></name><name><surname>Wittig</surname><given-names>I</given-names></name><name><surname>Zwicker</surname><given-names>K</given-names></name><name><surname>Zickermann</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Accessory subunit NUYM (Ndufs4) is required for stability of the electron input Module and activity of mitochondrial complex I</article-title><source>Biochimica et Biophysica Acta - Bioenergetics</source><volume>1858</volume><fpage>175</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1016/j.bbabio.2016.11.010</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Käll</surname><given-names>L</given-names></name><name><surname>Canterbury</surname><given-names>JD</given-names></name><name><surname>Weston</surname><given-names>J</given-names></name><name><surname>Noble</surname><given-names>WS</given-names></name><name><surname>MacCoss</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Semi-supervised learning for peptide identification from shotgun proteomics datasets</article-title><source>Nature Methods</source><volume>4</volume><fpage>923</fpage><lpage>925</lpage><pub-id pub-id-type="doi">10.1038/nmeth1113</pub-id><pub-id pub-id-type="pmid">17952086</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Käll</surname><given-names>L</given-names></name><name><surname>Storey</surname><given-names>JD</given-names></name><name><surname>Noble</surname><given-names>WS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>QVALITY: non-parametric estimation of Q-values and posterior error probabilities</article-title><source>Bioinformatics</source><volume>25</volume><fpage>964</fpage><lpage>966</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp021</pub-id><pub-id pub-id-type="pmid">19193729</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karamanlidis</surname><given-names>G</given-names></name><name><surname>Lee</surname><given-names>CF</given-names></name><name><surname>Garcia-Menendez</surname><given-names>L</given-names></name><name><surname>Kolwicz</surname><given-names>SC</given-names></name><name><surname>Suthammarak</surname><given-names>W</given-names></name><name><surname>Gong</surname><given-names>G</given-names></name><name><surname>Sedensky</surname><given-names>MM</given-names></name><name><surname>Morgan</surname><given-names>PG</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Tian</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mitochondrial complex I deficiency increases protein Acetylation and accelerates heart failure</article-title><source>Cell Metabolism</source><volume>18</volume><fpage>239</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2013.07.002</pub-id><pub-id pub-id-type="pmid">23931755</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>MP</given-names></name><name><surname>Paul</surname><given-names>PK</given-names></name><name><surname>Rabaglia</surname><given-names>ME</given-names></name><name><surname>Stapleton</surname><given-names>DS</given-names></name><name><surname>Schueler</surname><given-names>KL</given-names></name><name><surname>Broman</surname><given-names>AT</given-names></name><name><surname>Ye</surname><given-names>SI</given-names></name><name><surname>Leng</surname><given-names>N</given-names></name><name><surname>Brandon</surname><given-names>CJ</given-names></name><name><surname>Neto</surname><given-names>EC</given-names></name><name><surname>Plaisier</surname><given-names>CL</given-names></name><name><surname>Simonett</surname><given-names>SP</given-names></name><name><surname>Kebede</surname><given-names>MA</given-names></name><name><surname>Sheynkman</surname><given-names>GM</given-names></name><name><surname>Klein</surname><given-names>MA</given-names></name><name><surname>Baliga</surname><given-names>NS</given-names></name><name><surname>Smith</surname><given-names>LM</given-names></name><name><surname>Broman</surname><given-names>KW</given-names></name><name><surname>Yandell</surname><given-names>BS</given-names></name><name><surname>Kendziorski</surname><given-names>C</given-names></name><name><surname>Attie</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The transcription factor Nfatc2 regulates beta-cell proliferation and genes associated with type 2 diabetes in mouse and human Islets</article-title><source>PLOS Genetics</source><volume>12</volume><elocation-id>e1006466</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1006466</pub-id><pub-id pub-id-type="pmid">27935966</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>MP</given-names></name><name><surname>Gatti</surname><given-names>DM</given-names></name><name><surname>Schueler</surname><given-names>KL</given-names></name><name><surname>Rabaglia</surname><given-names>ME</given-names></name><name><surname>Stapleton</surname><given-names>DS</given-names></name><name><surname>Simecek</surname><given-names>P</given-names></name><name><surname>Vincent</surname><given-names>M</given-names></name><name><surname>Allen</surname><given-names>S</given-names></name><name><surname>Broman</surname><given-names>AT</given-names></name><name><surname>Bacher</surname><given-names>R</given-names></name><name><surname>Kendziorski</surname><given-names>C</given-names></name><name><surname>Broman</surname><given-names>KW</given-names></name><name><surname>Yandell</surname><given-names>BS</given-names></name><name><surname>Churchill</surname><given-names>GA</given-names></name><name><surname>Attie</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genetic drivers of Pancreatic Islet function</article-title><source>Genetics</source><volume>209</volume><fpage>335</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1534/genetics.118.300864</pub-id><pub-id pub-id-type="pmid">29567659</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>MP</given-names></name><name><surname>Rabaglia</surname><given-names>ME</given-names></name><name><surname>Schueler</surname><given-names>KL</given-names></name><name><surname>Stapleton</surname><given-names>DS</given-names></name><name><surname>Gatti</surname><given-names>DM</given-names></name><name><surname>Vincent</surname><given-names>M</given-names></name><name><surname>Mitok</surname><given-names>KA</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Ishimura</surname><given-names>T</given-names></name><name><surname>Simonett</surname><given-names>SP</given-names></name><name><surname>Emfinger</surname><given-names>CH</given-names></name><name><surname>Das</surname><given-names>R</given-names></name><name><surname>Beck</surname><given-names>T</given-names></name><name><surname>Kendziorski</surname><given-names>C</given-names></name><name><surname>Broman</surname><given-names>KW</given-names></name><name><surname>Yandell</surname><given-names>BS</given-names></name><name><surname>Churchill</surname><given-names>GA</given-names></name><name><surname>Attie</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Gene Loci associated with insulin secretion in Islets from non-diabetic mice</article-title><source>The Journal of Clinical Investigation</source><volume>129</volume><fpage>4419</fpage><lpage>4432</lpage><pub-id pub-id-type="doi">10.1172/JCI129143</pub-id><pub-id pub-id-type="pmid">31343992</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JA</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Sowers</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Role of mitochondrial dysfunction in insulin resistance</article-title><source>Circulation Research</source><volume>102</volume><fpage>401</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.107.165472</pub-id><pub-id pub-id-type="pmid">18309108</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Bi</surname><given-names>J</given-names></name><name><surname>Qi</surname><given-names>H</given-names></name><name><surname>Di</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Zha</surname><given-names>J</given-names></name><name><surname>Lv</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Ding</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Glucocorticoids Transcriptionally regulate miR-27B expression promoting body fat accumulation via suppressing the Browning of white adipose tissue</article-title><source>Diabetes</source><volume>64</volume><fpage>393</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.2337/db14-0395</pub-id><pub-id pub-id-type="pmid">25187367</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kozomara</surname><given-names>A</given-names></name><name><surname>Griffiths-Jones</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>miRBase: integrating microRNA Annotation and deep-sequencing data</article-title><source>Nucleic Acids Research</source><volume>39</volume><fpage>D152</fpage><lpage>D157</lpage><pub-id pub-id-type="doi">10.1093/nar/gkq1027</pub-id><pub-id pub-id-type="pmid">21037258</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langfelder</surname><given-names>P</given-names></name><name><surname>Horvath</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>WGCNA: an R package for weighted correlation network analysis</article-title><source>BMC Bioinformatics</source><volume>9</volume><elocation-id>559</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2105-9-559</pub-id><pub-id pub-id-type="pmid">19114008</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lapointe</surname><given-names>J</given-names></name><name><surname>Hekimi</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Early mitochondrial dysfunction in long-lived Mclk1+/- mice</article-title><source>The Journal of Biological Chemistry</source><volume>283</volume><fpage>26217</fpage><lpage>26227</lpage><pub-id pub-id-type="doi">10.1074/jbc.M803287200</pub-id><pub-id pub-id-type="pmid">18635541</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lapointe</surname><given-names>J</given-names></name><name><surname>Stepanyan</surname><given-names>Z</given-names></name><name><surname>Bigras</surname><given-names>E</given-names></name><name><surname>Hekimi</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Reversal of the mitochondrial phenotype and slow development of oxidative biomarkers of aging in long-lived Mclk1+/- mice</article-title><source>The Journal of Biological Chemistry</source><volume>284</volume><fpage>20364</fpage><lpage>20374</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.006569</pub-id><pub-id pub-id-type="pmid">19478076</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lapointe</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Bigras</surname><given-names>E</given-names></name><name><surname>Hekimi</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The Submitochondrial distribution of Ubiquinone affects respiration in long-lived Mclk1+/- mice</article-title><source>The Journal of Cell Biology</source><volume>199</volume><fpage>215</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1083/jcb.201203090</pub-id><pub-id pub-id-type="pmid">23045551</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leong</surname><given-names>DW</given-names></name><name><surname>Komen</surname><given-names>JC</given-names></name><name><surname>Hewitt</surname><given-names>CA</given-names></name><name><surname>Arnaud</surname><given-names>E</given-names></name><name><surname>McKenzie</surname><given-names>M</given-names></name><name><surname>Phipson</surname><given-names>B</given-names></name><name><surname>Bahlo</surname><given-names>M</given-names></name><name><surname>Laskowski</surname><given-names>A</given-names></name><name><surname>Kinkel</surname><given-names>SA</given-names></name><name><surname>Davey</surname><given-names>GM</given-names></name><name><surname>Heath</surname><given-names>WR</given-names></name><name><surname>Voss</surname><given-names>AK</given-names></name><name><surname>Zahedi</surname><given-names>RP</given-names></name><name><surname>Pitt</surname><given-names>JJ</given-names></name><name><surname>Chrast</surname><given-names>R</given-names></name><name><surname>Sickmann</surname><given-names>A</given-names></name><name><surname>Ryan</surname><given-names>MT</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name><name><surname>Thorburn</surname><given-names>DR</given-names></name><name><surname>Scott</surname><given-names>HS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Proteomic and Metabolomic analyses of mitochondrial complex I-deficient mouse model generated by spontaneous B2 short interspersed nuclear element (SINE) insertion into NADH dehydrogenase (Ubiquinone) Fe-S protein 4 (Ndufs4) Gene</article-title><source>The Journal of Biological Chemistry</source><volume>287</volume><fpage>20652</fpage><lpage>20663</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.327601</pub-id><pub-id pub-id-type="pmid">22535952</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leshinsky-Silver</surname><given-names>E</given-names></name><name><surname>Lebre</surname><given-names>A-S</given-names></name><name><surname>Minai</surname><given-names>L</given-names></name><name><surname>Saada</surname><given-names>A</given-names></name><name><surname>Steffann</surname><given-names>J</given-names></name><name><surname>Cohen</surname><given-names>S</given-names></name><name><surname>Rötig</surname><given-names>A</given-names></name><name><surname>Munnich</surname><given-names>A</given-names></name><name><surname>Lev</surname><given-names>D</given-names></name><name><surname>Lerman-Sagie</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Ndufs4 mutations cause Leigh syndrome with predominant brainstem involvement</article-title><source>Molecular Genetics and Metabolism</source><volume>97</volume><fpage>185</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1016/j.ymgme.2009.03.002</pub-id><pub-id pub-id-type="pmid">19364667</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Shao</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>HC</given-names></name><name><surname>Zhi</surname><given-names>Y</given-names></name><name><surname>Qiao</surname><given-names>B</given-names></name><name><surname>Ma</surname><given-names>K</given-names></name><name><surname>Du</surname><given-names>J</given-names></name><name><surname>Lai</surname><given-names>YQ</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Microrna-27B-3P down-regulates Fgf1 and aggravates pathological cardiac remodelling</article-title><source>Cardiovascular Research</source><volume>118</volume><fpage>2139</fpage><lpage>2151</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvab248</pub-id><pub-id pub-id-type="pmid">34358309</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lippert</surname><given-names>C</given-names></name><name><surname>Listgarten</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Kadie</surname><given-names>CM</given-names></name><name><surname>Davidson</surname><given-names>RI</given-names></name><name><surname>Heckerman</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Fast linear mixed models for genome-wide Association studies</article-title><source>Nature Methods</source><volume>8</volume><fpage>833</fpage><lpage>835</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1681</pub-id><pub-id pub-id-type="pmid">21892150</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>N</given-names></name><name><surname>Hughes</surname><given-names>B</given-names></name><name><surname>Bigras</surname><given-names>E</given-names></name><name><surname>Shoubridge</surname><given-names>E</given-names></name><name><surname>Hekimi</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Evolutionary conservation of the Clk-1-dependent mechanism of longevity: loss of Mclk1 increases cellular fitness and lifespan in mice</article-title><source>Genes &amp; Development</source><volume>19</volume><fpage>2424</fpage><lpage>2434</lpage><pub-id pub-id-type="doi">10.1101/gad.1352905</pub-id><pub-id pub-id-type="pmid">16195414</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lusis</surname><given-names>AJ</given-names></name><name><surname>Seldin</surname><given-names>MM</given-names></name><name><surname>Allayee</surname><given-names>H</given-names></name><name><surname>Bennett</surname><given-names>BJ</given-names></name><name><surname>Civelek</surname><given-names>M</given-names></name><name><surname>Davis</surname><given-names>RC</given-names></name><name><surname>Eskin</surname><given-names>E</given-names></name><name><surname>Farber</surname><given-names>CR</given-names></name><name><surname>Hui</surname><given-names>S</given-names></name><name><surname>Mehrabian</surname><given-names>M</given-names></name><name><surname>Norheim</surname><given-names>F</given-names></name><name><surname>Pan</surname><given-names>C</given-names></name><name><surname>Parks</surname><given-names>B</given-names></name><name><surname>Rau</surname><given-names>CD</given-names></name><name><surname>Smith</surname><given-names>DJ</given-names></name><name><surname>Vallim</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The hybrid mouse diversity panel: a resource for systems Genetics analyses of metabolic and cardiovascular traits</article-title><source>Journal of Lipid Research</source><volume>57</volume><fpage>925</fpage><lpage>942</lpage><pub-id pub-id-type="doi">10.1194/jlr.R066944</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McAlister</surname><given-names>GC</given-names></name><name><surname>Nusinow</surname><given-names>DP</given-names></name><name><surname>Jedrychowski</surname><given-names>MP</given-names></name><name><surname>Wühr</surname><given-names>M</given-names></name><name><surname>Huttlin</surname><given-names>EL</given-names></name><name><surname>Erickson</surname><given-names>BK</given-names></name><name><surname>Rad</surname><given-names>R</given-names></name><name><surname>Haas</surname><given-names>W</given-names></name><name><surname>Gygi</surname><given-names>SP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Multinotch Ms3 enables accurate, sensitive, and Multiplexed detection of differential expression across cancer cell line Proteomes</article-title><source>Analytical Chemistry</source><volume>86</volume><fpage>7150</fpage><lpage>7158</lpage><pub-id pub-id-type="doi">10.1021/ac502040v</pub-id><pub-id pub-id-type="pmid">24927332</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mootha</surname><given-names>VK</given-names></name><name><surname>Lepage</surname><given-names>P</given-names></name><name><surname>Miller</surname><given-names>K</given-names></name><name><surname>Bunkenborg</surname><given-names>J</given-names></name><name><surname>Reich</surname><given-names>M</given-names></name><name><surname>Hjerrild</surname><given-names>M</given-names></name><name><surname>Delmonte</surname><given-names>T</given-names></name><name><surname>Villeneuve</surname><given-names>A</given-names></name><name><surname>Sladek</surname><given-names>R</given-names></name><name><surname>Xu</surname><given-names>F</given-names></name><name><surname>Mitchell</surname><given-names>GA</given-names></name><name><surname>Morin</surname><given-names>C</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name><name><surname>Hudson</surname><given-names>TJ</given-names></name><name><surname>Robinson</surname><given-names>B</given-names></name><name><surname>Rioux</surname><given-names>JD</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Identification of a gene causing human cytochrome C oxidase deficiency by integrative Genomics</article-title><source>PNAS</source><volume>100</volume><fpage>605</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1073/pnas.242716699</pub-id><pub-id pub-id-type="pmid">12529507</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>AP</given-names></name><name><surname>Fu</surname><given-names>CP</given-names></name><name><surname>Kao</surname><given-names>CY</given-names></name><name><surname>Welsh</surname><given-names>CE</given-names></name><name><surname>Didion</surname><given-names>JP</given-names></name><name><surname>Yadgary</surname><given-names>L</given-names></name><name><surname>Hyacinth</surname><given-names>L</given-names></name><name><surname>Ferris</surname><given-names>MT</given-names></name><name><surname>Bell</surname><given-names>TA</given-names></name><name><surname>Miller</surname><given-names>DR</given-names></name><name><surname>Giusti-Rodriguez</surname><given-names>P</given-names></name><name><surname>Nonneman</surname><given-names>RJ</given-names></name><name><surname>Cook</surname><given-names>KD</given-names></name><name><surname>Whitmire</surname><given-names>JK</given-names></name><name><surname>Gralinski</surname><given-names>LE</given-names></name><name><surname>Keller</surname><given-names>M</given-names></name><name><surname>Attie</surname><given-names>AD</given-names></name><name><surname>Churchill</surname><given-names>GA</given-names></name><name><surname>Petkov</surname><given-names>P</given-names></name><name><surname>Sullivan</surname><given-names>PF</given-names></name><name><surname>Brennan</surname><given-names>JR</given-names></name><name><surname>McMillan</surname><given-names>L</given-names></name><name><surname>Pardo-Manuel de Villena</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The mouse universal Genotyping array: from Substrains to subspecies</article-title><source>G3: Genes, Genomes, Genetics</source><volume>6</volume><fpage>263</fpage><lpage>279</lpage><pub-id pub-id-type="doi">10.1534/g3.115.022087</pub-id><pub-id pub-id-type="pmid">26684931</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>E</given-names></name><name><surname>Ardehali</surname><given-names>H</given-names></name><name><surname>Balaban</surname><given-names>RS</given-names></name><name><surname>DiLisa</surname><given-names>F</given-names></name><name><surname>Dorn</surname><given-names>GW</given-names></name><name><surname>Kitsis</surname><given-names>RN</given-names></name><name><surname>Otsu</surname><given-names>K</given-names></name><name><surname>Ping</surname><given-names>P</given-names></name><name><surname>Rizzuto</surname><given-names>R</given-names></name><name><surname>Sack</surname><given-names>MN</given-names></name><name><surname>Wallace</surname><given-names>D</given-names></name><name><surname>Youle</surname><given-names>RJ</given-names></name><collab>American Heart Association Council on Basic Cardiovascular Sciences, Council on Clinical Cardiology, and Council on Functional Genomics and Translational Biology</collab></person-group><year iso-8601-date="2016">2016</year><article-title>Mitochondrial function, biology, and role in disease: A scientific statement from the American heart Association</article-title><source>Circulation Research</source><volume>118</volume><fpage>1960</fpage><lpage>1991</lpage><pub-id pub-id-type="doi">10.1161/RES.0000000000000104</pub-id><pub-id pub-id-type="pmid">27126807</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakai</surname><given-names>D</given-names></name><name><surname>Yuasa</surname><given-names>S</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Shimizu</surname><given-names>T</given-names></name><name><surname>Asaumi</surname><given-names>S</given-names></name><name><surname>Isono</surname><given-names>K</given-names></name><name><surname>Takao</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Kuroyanagi</surname><given-names>H</given-names></name><name><surname>Hirokawa</surname><given-names>K</given-names></name><name><surname>Koseki</surname><given-names>H</given-names></name><name><surname>Shirsawa</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Mouse Homologue of Coq7/Clk-1, longevity Gene in <italic>Caenorhabditis elegans</italic>, is essential for coenzyme Q synthesis, maintenance of mitochondrial integrity, and neurogenesis</article-title><source>Biochemical and Biophysical Research Communications</source><volume>289</volume><fpage>463</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1006/bbrc.2001.5977</pub-id><pub-id pub-id-type="pmid">11716496</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norheim</surname><given-names>F</given-names></name><name><surname>Hui</surname><given-names>ST</given-names></name><name><surname>Kulahcioglu</surname><given-names>E</given-names></name><name><surname>Mehrabian</surname><given-names>M</given-names></name><name><surname>Cantor</surname><given-names>RM</given-names></name><name><surname>Pan</surname><given-names>C</given-names></name><name><surname>Parks</surname><given-names>BW</given-names></name><name><surname>Lusis</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Genetic and hormonal control of hepatic steatosis in female and male mice</article-title><source>Journal of Lipid Research</source><volume>58</volume><fpage>178</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1194/jlr.M071522</pub-id><pub-id pub-id-type="pmid">27811231</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norheim</surname><given-names>F</given-names></name><name><surname>Bjellaas</surname><given-names>T</given-names></name><name><surname>Hui</surname><given-names>ST</given-names></name><name><surname>Chella Krishnan</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Pan</surname><given-names>C</given-names></name><name><surname>Hasin-Brumshtein</surname><given-names>Y</given-names></name><name><surname>Parks</surname><given-names>BW</given-names></name><name><surname>Li</surname><given-names>DY</given-names></name><name><surname>Bui</surname><given-names>HH</given-names></name><name><surname>Mosier</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Huertas-Vazquez</surname><given-names>A</given-names></name><name><surname>Hazen</surname><given-names>SL</given-names></name><name><surname>Gundersen</surname><given-names>TE</given-names></name><name><surname>Mehrabian</surname><given-names>M</given-names></name><name><surname>Tang</surname><given-names>WHW</given-names></name><name><surname>Hevener</surname><given-names>AL</given-names></name><name><surname>Drevon</surname><given-names>CA</given-names></name><name><surname>Lusis</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genetic, dietary, and sex-specific regulation of hepatic Ceramides and the relationship between hepatic Ceramides and IR</article-title><source>Journal of Lipid Research</source><volume>59</volume><fpage>1164</fpage><lpage>1174</lpage><pub-id pub-id-type="doi">10.1194/jlr.M081398</pub-id><pub-id pub-id-type="pmid">29739864</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norheim</surname><given-names>F</given-names></name><name><surname>Hasin-Brumshtein</surname><given-names>Y</given-names></name><name><surname>Vergnes</surname><given-names>L</given-names></name><name><surname>Chella Krishnan</surname><given-names>K</given-names></name><name><surname>Pan</surname><given-names>C</given-names></name><name><surname>Seldin</surname><given-names>MM</given-names></name><name><surname>Hui</surname><given-names>ST</given-names></name><name><surname>Mehrabian</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Parks</surname><given-names>BW</given-names></name><name><surname>Walch</surname><given-names>A</given-names></name><name><surname>Reue</surname><given-names>K</given-names></name><name><surname>Hofmann</surname><given-names>SM</given-names></name><name><surname>Arnold</surname><given-names>AP</given-names></name><name><surname>Lusis</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Gene-by-sex interactions in mitochondrial functions and Cardio-metabolic traits</article-title><source>Cell Metabolism</source><volume>29</volume><fpage>932</fpage><lpage>949</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2018.12.013</pub-id><pub-id pub-id-type="pmid">30639359</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oláhová</surname><given-names>M</given-names></name><name><surname>Hardy</surname><given-names>SA</given-names></name><name><surname>Hall</surname><given-names>J</given-names></name><name><surname>Yarham</surname><given-names>JW</given-names></name><name><surname>Haack</surname><given-names>TB</given-names></name><name><surname>Wilson</surname><given-names>WC</given-names></name><name><surname>Alston</surname><given-names>CL</given-names></name><name><surname>He</surname><given-names>L</given-names></name><name><surname>Aznauryan</surname><given-names>E</given-names></name><name><surname>Brown</surname><given-names>RM</given-names></name><name><surname>Brown</surname><given-names>GK</given-names></name><name><surname>Morris</surname><given-names>AAM</given-names></name><name><surname>Mundy</surname><given-names>H</given-names></name><name><surname>Broomfield</surname><given-names>A</given-names></name><name><surname>Barbosa</surname><given-names>IA</given-names></name><name><surname>Simpson</surname><given-names>MA</given-names></name><name><surname>Deshpande</surname><given-names>C</given-names></name><name><surname>Moeslinger</surname><given-names>D</given-names></name><name><surname>Koch</surname><given-names>J</given-names></name><name><surname>Stettner</surname><given-names>GM</given-names></name><name><surname>Bonnen</surname><given-names>PE</given-names></name><name><surname>Prokisch</surname><given-names>H</given-names></name><name><surname>Lightowlers</surname><given-names>RN</given-names></name><name><surname>McFarland</surname><given-names>R</given-names></name><name><surname>Chrzanowska-Lightowlers</surname><given-names>ZMA</given-names></name><name><surname>Taylor</surname><given-names>RW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>LRPPRC mutations cause early-onset Multisystem mitochondrial disease outside of the French-Canadian population</article-title><source>Brain</source><volume>138</volume><fpage>3503</fpage><lpage>3519</lpage><pub-id pub-id-type="doi">10.1093/brain/awv291</pub-id><pub-id pub-id-type="pmid">26510951</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Org</surname><given-names>E</given-names></name><name><surname>Mehrabian</surname><given-names>M</given-names></name><name><surname>Parks</surname><given-names>BW</given-names></name><name><surname>Shipkova</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Drake</surname><given-names>TA</given-names></name><name><surname>Lusis</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Sex differences and hormonal effects on gut Microbiota composition in mice</article-title><source>Gut Microbes</source><volume>7</volume><fpage>313</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1080/19490976.2016.1203502</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parks</surname><given-names>BW</given-names></name><name><surname>Nam</surname><given-names>E</given-names></name><name><surname>Org</surname><given-names>E</given-names></name><name><surname>Kostem</surname><given-names>E</given-names></name><name><surname>Norheim</surname><given-names>F</given-names></name><name><surname>Hui</surname><given-names>ST</given-names></name><name><surname>Pan</surname><given-names>C</given-names></name><name><surname>Civelek</surname><given-names>M</given-names></name><name><surname>Rau</surname><given-names>CD</given-names></name><name><surname>Bennett</surname><given-names>BJ</given-names></name><name><surname>Mehrabian</surname><given-names>M</given-names></name><name><surname>Ursell</surname><given-names>LK</given-names></name><name><surname>He</surname><given-names>A</given-names></name><name><surname>Castellani</surname><given-names>LW</given-names></name><name><surname>Zinker</surname><given-names>B</given-names></name><name><surname>Kirby</surname><given-names>M</given-names></name><name><surname>Drake</surname><given-names>TA</given-names></name><name><surname>Drevon</surname><given-names>CA</given-names></name><name><surname>Knight</surname><given-names>R</given-names></name><name><surname>Gargalovic</surname><given-names>P</given-names></name><name><surname>Kirchgessner</surname><given-names>T</given-names></name><name><surname>Eskin</surname><given-names>E</given-names></name><name><surname>Lusis</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Genetic control of obesity and gut Microbiota composition in response to high-fat, high-Sucrose diet in mice</article-title><source>Cell Metabolism</source><volume>17</volume><fpage>141</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2012.12.007</pub-id><pub-id pub-id-type="pmid">23312289</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parks</surname><given-names>BW</given-names></name><name><surname>Sallam</surname><given-names>T</given-names></name><name><surname>Mehrabian</surname><given-names>M</given-names></name><name><surname>Psychogios</surname><given-names>N</given-names></name><name><surname>Hui</surname><given-names>ST</given-names></name><name><surname>Norheim</surname><given-names>F</given-names></name><name><surname>Castellani</surname><given-names>LW</given-names></name><name><surname>Rau</surname><given-names>CD</given-names></name><name><surname>Pan</surname><given-names>C</given-names></name><name><surname>Phun</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>W-P</given-names></name><name><surname>Neuhaus</surname><given-names>I</given-names></name><name><surname>Gargalovic</surname><given-names>PS</given-names></name><name><surname>Kirchgessner</surname><given-names>TG</given-names></name><name><surname>Graham</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>R</given-names></name><name><surname>Tontonoz</surname><given-names>P</given-names></name><name><surname>Gerszten</surname><given-names>RE</given-names></name><name><surname>Hevener</surname><given-names>AL</given-names></name><name><surname>Lusis</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Genetic architecture of insulin resistance in the mouse</article-title><source>Cell Metabolism</source><volume>21</volume><fpage>334</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2015.01.002</pub-id><pub-id pub-id-type="pmid">25651185</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Riverol</surname><given-names>Y</given-names></name><name><surname>Bai</surname><given-names>J</given-names></name><name><surname>Bandla</surname><given-names>C</given-names></name><name><surname>García-Seisdedos</surname><given-names>D</given-names></name><name><surname>Hewapathirana</surname><given-names>S</given-names></name><name><surname>Kamatchinathan</surname><given-names>S</given-names></name><name><surname>Kundu</surname><given-names>DJ</given-names></name><name><surname>Prakash</surname><given-names>A</given-names></name><name><surname>Frericks-Zipper</surname><given-names>A</given-names></name><name><surname>Eisenacher</surname><given-names>M</given-names></name><name><surname>Walzer</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Brazma</surname><given-names>A</given-names></name><name><surname>Vizcaíno</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The PRIDE database resources in 2022: a Hub for mass Spectrometry-based Proteomics evidences</article-title><source>Nucleic Acids Research</source><volume>50</volume><fpage>D543</fpage><lpage>D552</lpage><pub-id pub-id-type="doi">10.1093/nar/gkab1038</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rath</surname><given-names>S</given-names></name><name><surname>Sharma</surname><given-names>R</given-names></name><name><surname>Gupta</surname><given-names>R</given-names></name><name><surname>Ast</surname><given-names>T</given-names></name><name><surname>Chan</surname><given-names>C</given-names></name><name><surname>Durham</surname><given-names>TJ</given-names></name><name><surname>Goodman</surname><given-names>RP</given-names></name><name><surname>Grabarek</surname><given-names>Z</given-names></name><name><surname>Haas</surname><given-names>ME</given-names></name><name><surname>Hung</surname><given-names>WHW</given-names></name><name><surname>Joshi</surname><given-names>PR</given-names></name><name><surname>Jourdain</surname><given-names>AA</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Kotrys</surname><given-names>AV</given-names></name><name><surname>Lam</surname><given-names>SS</given-names></name><name><surname>McCoy</surname><given-names>JG</given-names></name><name><surname>Meisel</surname><given-names>JD</given-names></name><name><surname>Miranda</surname><given-names>M</given-names></name><name><surname>Panda</surname><given-names>A</given-names></name><name><surname>Patgiri</surname><given-names>A</given-names></name><name><surname>Rogers</surname><given-names>R</given-names></name><name><surname>Sadre</surname><given-names>S</given-names></name><name><surname>Shah</surname><given-names>H</given-names></name><name><surname>Skinner</surname><given-names>OS</given-names></name><name><surname>To</surname><given-names>T-L</given-names></name><name><surname>Walker</surname><given-names>MA</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Ward</surname><given-names>PS</given-names></name><name><surname>Wengrod</surname><given-names>J</given-names></name><name><surname>Yuan</surname><given-names>C-C</given-names></name><name><surname>Calvo</surname><given-names>SE</given-names></name><name><surname>Mootha</surname><given-names>VK</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Mitocarta3.0: an updated mitochondrial Proteome now with sub-Organelle localization and pathway annotations</article-title><source>Nucleic Acids Research</source><volume>49</volume><fpage>D1541</fpage><lpage>D1547</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa1011</pub-id><pub-id pub-id-type="pmid">31822909</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rau</surname><given-names>CD</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Avetisyan</surname><given-names>R</given-names></name><name><surname>Romay</surname><given-names>MC</given-names></name><name><surname>Martin</surname><given-names>L</given-names></name><name><surname>Ren</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Lusis</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mapping genetic contributions to cardiac pathology induced by beta-adrenergic stimulation in mice</article-title><source>Circulation. Cardiovascular Genetics</source><volume>8</volume><fpage>40</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1161/CIRCGENETICS.113.000732</pub-id><pub-id pub-id-type="pmid">25480693</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rau</surname><given-names>CD</given-names></name><name><surname>Romay</surname><given-names>MC</given-names></name><name><surname>Tuteryan</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>JJC</given-names></name><name><surname>Santolini</surname><given-names>M</given-names></name><name><surname>Ren</surname><given-names>S</given-names></name><name><surname>Karma</surname><given-names>A</given-names></name><name><surname>Weiss</surname><given-names>JN</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Lusis</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Systems Genetics approach identifies Gene pathways and Adamts2 as drivers of isoproterenol-induced cardiac hypertrophy and cardiomyopathy in mice</article-title><source>Cell Systems</source><volume>4</volume><fpage>121</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1016/j.cels.2016.10.016</pub-id><pub-id pub-id-type="pmid">27866946</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruffieux</surname><given-names>H</given-names></name><name><surname>Carayol</surname><given-names>J</given-names></name><name><surname>Popescu</surname><given-names>R</given-names></name><name><surname>Harper</surname><given-names>ME</given-names></name><name><surname>Dent</surname><given-names>R</given-names></name><name><surname>Saris</surname><given-names>WHM</given-names></name><name><surname>Astrup</surname><given-names>A</given-names></name><name><surname>Hager</surname><given-names>J</given-names></name><name><surname>Davison</surname><given-names>AC</given-names></name><name><surname>Valsesia</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A fully joint Bayesian quantitative trait locus mapping of human protein abundance in plasma</article-title><source>PLOS Computational Biology</source><volume>16</volume><elocation-id>e1007882</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1007882</pub-id><pub-id pub-id-type="pmid">32492067</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruzzenente</surname><given-names>B</given-names></name><name><surname>Metodiev</surname><given-names>MD</given-names></name><name><surname>Wredenberg</surname><given-names>A</given-names></name><name><surname>Bratic</surname><given-names>A</given-names></name><name><surname>Park</surname><given-names>CB</given-names></name><name><surname>Cámara</surname><given-names>Y</given-names></name><name><surname>Milenkovic</surname><given-names>D</given-names></name><name><surname>Zickermann</surname><given-names>V</given-names></name><name><surname>Wibom</surname><given-names>R</given-names></name><name><surname>Hultenby</surname><given-names>K</given-names></name><name><surname>Erdjument-Bromage</surname><given-names>H</given-names></name><name><surname>Tempst</surname><given-names>P</given-names></name><name><surname>Brandt</surname><given-names>U</given-names></name><name><surname>Stewart</surname><given-names>JB</given-names></name><name><surname>Gustafsson</surname><given-names>CM</given-names></name><name><surname>Larsson</surname><given-names>N-G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>LRPPRC is necessary for Polyadenylation and coordination of translation of mitochondrial mRNAs</article-title><source>The EMBO Journal</source><volume>31</volume><fpage>443</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1038/emboj.2011.392</pub-id><pub-id pub-id-type="pmid">22045337</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanyal</surname><given-names>AJ</given-names></name><name><surname>Campbell–Sargent</surname><given-names>C</given-names></name><name><surname>Mirshahi</surname><given-names>F</given-names></name><name><surname>Rizzo</surname><given-names>WB</given-names></name><name><surname>Contos</surname><given-names>MJ</given-names></name><name><surname>Sterling</surname><given-names>RK</given-names></name><name><surname>Luketic</surname><given-names>VA</given-names></name><name><surname>Shiffman</surname><given-names>ML</given-names></name><name><surname>Clore</surname><given-names>JN</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Nonalcoholic Steatohepatitis: Association of insulin resistance and mitochondrial abnormalities</article-title><source>Gastroenterology</source><volume>120</volume><fpage>1183</fpage><lpage>1192</lpage><pub-id pub-id-type="doi">10.1053/gast.2001.23256</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scacco</surname><given-names>S</given-names></name><name><surname>Petruzzella</surname><given-names>V</given-names></name><name><surname>Budde</surname><given-names>S</given-names></name><name><surname>Vergari</surname><given-names>R</given-names></name><name><surname>Tamborra</surname><given-names>R</given-names></name><name><surname>Panelli</surname><given-names>D</given-names></name><name><surname>van den Heuvel</surname><given-names>LP</given-names></name><name><surname>Smeitink</surname><given-names>JA</given-names></name><name><surname>Papa</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Pathological mutations of the human Ndufs4 Gene of the 18-kDa (AQDQ) subunit of complex I affect the expression of the protein and the assembly and function of the complex</article-title><source>The Journal of Biological Chemistry</source><volume>278</volume><fpage>44161</fpage><lpage>44167</lpage><pub-id pub-id-type="doi">10.1074/jbc.M307615200</pub-id><pub-id pub-id-type="pmid">12944388</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seldin</surname><given-names>MM</given-names></name><name><surname>Kim</surname><given-names>ED</given-names></name><name><surname>Romay</surname><given-names>MC</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Rau</surname><given-names>CD</given-names></name><name><surname>Wang</surname><given-names>JJ</given-names></name><name><surname>Krishnan</surname><given-names>KC</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Deb</surname><given-names>A</given-names></name><name><surname>Lusis</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A systems Genetics approach identifies Trp53Inp2 as a link between cardiomyocyte glucose utilization and hypertrophic response</article-title><source>American Journal of Physiology. Heart and Circulatory Physiology</source><volume>312</volume><fpage>H728</fpage><lpage>H741</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00068.2016</pub-id><pub-id pub-id-type="pmid">28235788</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seldin</surname><given-names>MM</given-names></name><name><surname>Koplev</surname><given-names>S</given-names></name><name><surname>Rajbhandari</surname><given-names>P</given-names></name><name><surname>Vergnes</surname><given-names>L</given-names></name><name><surname>Rosenberg</surname><given-names>GM</given-names></name><name><surname>Meng</surname><given-names>Y</given-names></name><name><surname>Pan</surname><given-names>C</given-names></name><name><surname>Phuong</surname><given-names>TMN</given-names></name><name><surname>Gharakhanian</surname><given-names>R</given-names></name><name><surname>Che</surname><given-names>N</given-names></name><name><surname>Mäkinen</surname><given-names>S</given-names></name><name><surname>Shih</surname><given-names>DM</given-names></name><name><surname>Civelek</surname><given-names>M</given-names></name><name><surname>Parks</surname><given-names>BW</given-names></name><name><surname>Kim</surname><given-names>ED</given-names></name><name><surname>Norheim</surname><given-names>F</given-names></name><name><surname>Chella Krishnan</surname><given-names>K</given-names></name><name><surname>Hasin-Brumshtein</surname><given-names>Y</given-names></name><name><surname>Mehrabian</surname><given-names>M</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name><name><surname>Drevon</surname><given-names>CA</given-names></name><name><surname>Koistinen</surname><given-names>HA</given-names></name><name><surname>Tontonoz</surname><given-names>P</given-names></name><name><surname>Reue</surname><given-names>K</given-names></name><name><surname>Cantor</surname><given-names>RM</given-names></name><name><surname>Björkegren</surname><given-names>JLM</given-names></name><name><surname>Lusis</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A strategy for discovery of endocrine interactions with application to whole-body metabolism</article-title><source>Cell Metabolism</source><volume>27</volume><fpage>1138</fpage><lpage>1155</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2018.03.015</pub-id><pub-id pub-id-type="pmid">29719227</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seldin</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Lusis</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Systems Genetics applications in metabolism research</article-title><source>Nature Metabolism</source><volume>1</volume><fpage>1038</fpage><lpage>1050</lpage><pub-id pub-id-type="doi">10.1038/s42255-019-0132-x</pub-id><pub-id pub-id-type="pmid">32259026</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>A</given-names></name><name><surname>Fonarow</surname><given-names>GC</given-names></name><name><surname>Butler</surname><given-names>J</given-names></name><name><surname>Ezekowitz</surname><given-names>JA</given-names></name><name><surname>Felker</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Coenzyme Q10 and heart failure: A state-of-the-art review</article-title><source>Circulation. Heart Failure</source><volume>9</volume><elocation-id>e002639</elocation-id><pub-id pub-id-type="doi">10.1161/CIRCHEARTFAILURE.115.002639</pub-id><pub-id pub-id-type="pmid">27012265</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siira</surname><given-names>SJ</given-names></name><name><surname>Spåhr</surname><given-names>H</given-names></name><name><surname>Shearwood</surname><given-names>A-MJ</given-names></name><name><surname>Ruzzenente</surname><given-names>B</given-names></name><name><surname>Larsson</surname><given-names>N-G</given-names></name><name><surname>Rackham</surname><given-names>O</given-names></name><name><surname>Filipovska</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>LRPPRC-mediated folding of the mitochondrial transcriptome</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>1532</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-01221-z</pub-id><pub-id pub-id-type="pmid">29146908</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Small</surname><given-names>KS</given-names></name><name><surname>Todorčević</surname><given-names>M</given-names></name><name><surname>Civelek</surname><given-names>M</given-names></name><name><surname>El-Sayed Moustafa</surname><given-names>JS</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Simon</surname><given-names>MM</given-names></name><name><surname>Fernandez-Tajes</surname><given-names>J</given-names></name><name><surname>Mahajan</surname><given-names>A</given-names></name><name><surname>Horikoshi</surname><given-names>M</given-names></name><name><surname>Hugill</surname><given-names>A</given-names></name><name><surname>Glastonbury</surname><given-names>CA</given-names></name><name><surname>Quaye</surname><given-names>L</given-names></name><name><surname>Neville</surname><given-names>MJ</given-names></name><name><surname>Sethi</surname><given-names>S</given-names></name><name><surname>Yon</surname><given-names>M</given-names></name><name><surname>Pan</surname><given-names>C</given-names></name><name><surname>Che</surname><given-names>N</given-names></name><name><surname>Viñuela</surname><given-names>A</given-names></name><name><surname>Tsai</surname><given-names>P-C</given-names></name><name><surname>Nag</surname><given-names>A</given-names></name><name><surname>Buil</surname><given-names>A</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Raghavan</surname><given-names>A</given-names></name><name><surname>Ding</surname><given-names>Q</given-names></name><name><surname>Morris</surname><given-names>AP</given-names></name><name><surname>Bell</surname><given-names>JT</given-names></name><name><surname>Thorsteinsdottir</surname><given-names>U</given-names></name><name><surname>Stefansson</surname><given-names>K</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name><name><surname>Dahlman</surname><given-names>I</given-names></name><name><surname>Arner</surname><given-names>P</given-names></name><name><surname>Gloyn</surname><given-names>AL</given-names></name><name><surname>Musunuru</surname><given-names>K</given-names></name><name><surname>Lusis</surname><given-names>AJ</given-names></name><name><surname>Cox</surname><given-names>RD</given-names></name><name><surname>Karpe</surname><given-names>F</given-names></name><name><surname>McCarthy</surname><given-names>MI</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Regulatory variants at Klf14 influence type 2 diabetes risk via a female-specific effect on Adipocyte size and body composition</article-title><source>Nature Genetics</source><volume>50</volume><fpage>572</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0088-x</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stroud</surname><given-names>DA</given-names></name><name><surname>Surgenor</surname><given-names>EE</given-names></name><name><surname>Formosa</surname><given-names>LE</given-names></name><name><surname>Reljic</surname><given-names>B</given-names></name><name><surname>Frazier</surname><given-names>AE</given-names></name><name><surname>Dibley</surname><given-names>MG</given-names></name><name><surname>Osellame</surname><given-names>LD</given-names></name><name><surname>Stait</surname><given-names>T</given-names></name><name><surname>Beilharz</surname><given-names>TH</given-names></name><name><surname>Thorburn</surname><given-names>DR</given-names></name><name><surname>Salim</surname><given-names>A</given-names></name><name><surname>Ryan</surname><given-names>MT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Accessory subunits are integral for assembly and function of human mitochondrial complex I</article-title><source>Nature</source><volume>538</volume><fpage>123</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1038/nature19754</pub-id><pub-id pub-id-type="pmid">27626371</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Trajkovski</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mir-27 Orchestrates the transcriptional regulation of Brown Adipogenesis</article-title><source>Metabolism</source><volume>63</volume><fpage>272</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1016/j.metabol.2013.10.004</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Svenson</surname><given-names>KL</given-names></name><name><surname>Gatti</surname><given-names>DM</given-names></name><name><surname>Valdar</surname><given-names>W</given-names></name><name><surname>Welsh</surname><given-names>CE</given-names></name><name><surname>Cheng</surname><given-names>R</given-names></name><name><surname>Chesler</surname><given-names>EJ</given-names></name><name><surname>Palmer</surname><given-names>AA</given-names></name><name><surname>McMillan</surname><given-names>L</given-names></name><name><surname>Churchill</surname><given-names>GA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>High-resolution genetic mapping using the mouse diversity Outbred population</article-title><source>Genetics</source><volume>190</volume><fpage>437</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1534/genetics.111.132597</pub-id><pub-id pub-id-type="pmid">22345611</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mitochondrial genetic medicine</article-title><source>Nature Genetics</source><volume>50</volume><fpage>1642</fpage><lpage>1649</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0264-z</pub-id><pub-id pub-id-type="pmid">30374071</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Xiao</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Hou</surname><given-names>N</given-names></name><name><surname>Guo</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Fan</surname><given-names>K</given-names></name><name><surname>Zhan</surname><given-names>D</given-names></name><name><surname>Zha</surname><given-names>L</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Cheng</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Cardiomyocyte overexpression of miR-27B induces cardiac hypertrophy and dysfunction in mice</article-title><source>Cell Research</source><volume>22</volume><fpage>516</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1038/cr.2011.132</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Oxer</surname><given-names>D</given-names></name><name><surname>Hekimi</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mitochondrial function and LifeSpan of mice with controlled Ubiquinone biosynthesis</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>6393</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms7393</pub-id><pub-id pub-id-type="pmid">25744659</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>JJC</given-names></name><name><surname>Rau</surname><given-names>C</given-names></name><name><surname>Avetisyan</surname><given-names>R</given-names></name><name><surname>Ren</surname><given-names>S</given-names></name><name><surname>Romay</surname><given-names>MC</given-names></name><name><surname>Stolin</surname><given-names>G</given-names></name><name><surname>Gong</surname><given-names>KW</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Lusis</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Genetic dissection of cardiac remodeling in an isoproterenol-induced heart failure mouse model</article-title><source>PLOS Genetics</source><volume>12</volume><elocation-id>e1006038</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1006038</pub-id><pub-id pub-id-type="pmid">27385019</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Cai</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Gao</surname><given-names>Z</given-names></name><name><surname>Song</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Atrial overexpression of microRNA-27B attenuates angiotensin II-induced atrial fibrosis and fibrillation by targeting Alk5</article-title><source>Human Cell</source><volume>31</volume><fpage>251</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1007/s13577-018-0208-z</pub-id><pub-id pub-id-type="pmid">29671258</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Farias</surname><given-names>FHG</given-names></name><name><surname>Ibanez</surname><given-names>L</given-names></name><name><surname>Suhy</surname><given-names>A</given-names></name><name><surname>Sadler</surname><given-names>B</given-names></name><name><surname>Fernandez</surname><given-names>MV</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Bradley</surname><given-names>JL</given-names></name><name><surname>Eiffert</surname><given-names>B</given-names></name><name><surname>Bahena</surname><given-names>JA</given-names></name><name><surname>Budde</surname><given-names>JP</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Dube</surname><given-names>U</given-names></name><name><surname>Sung</surname><given-names>YJ</given-names></name><name><surname>Mihindukulasuriya</surname><given-names>KA</given-names></name><name><surname>Morris</surname><given-names>JC</given-names></name><name><surname>Fagan</surname><given-names>AM</given-names></name><name><surname>Perrin</surname><given-names>RJ</given-names></name><name><surname>Benitez</surname><given-names>BA</given-names></name><name><surname>Rhinn</surname><given-names>H</given-names></name><name><surname>Harari</surname><given-names>O</given-names></name><name><surname>Cruchaga</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Genomic Atlas of the Proteome from brain, CSF and plasma Prioritizes proteins implicated in neurological disorders</article-title><source>Nature Neuroscience</source><volume>24</volume><fpage>1302</fpage><lpage>1312</lpage><pub-id pub-id-type="doi">10.1038/s41593-021-00886-6</pub-id><pub-id pub-id-type="pmid">34239129</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>C</given-names></name><name><surname>Joehanes</surname><given-names>R</given-names></name><name><surname>Johnson</surname><given-names>AD</given-names></name><name><surname>Huan</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Freedman</surname><given-names>JE</given-names></name><name><surname>Munson</surname><given-names>PJ</given-names></name><name><surname>Hill</surname><given-names>DE</given-names></name><name><surname>Vidal</surname><given-names>M</given-names></name><name><surname>Levy</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Dynamic role of Trans regulation of gene expression in relation to complex traits</article-title><source>The American Journal of Human Genetics</source><volume>100</volume><fpage>571</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2017.02.003</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Song</surname><given-names>C</given-names></name><name><surname>Keefe</surname><given-names>J</given-names></name><name><surname>Mendelson</surname><given-names>M</given-names></name><name><surname>Huan</surname><given-names>T</given-names></name><name><surname>Sun</surname><given-names>BB</given-names></name><name><surname>Laser</surname><given-names>A</given-names></name><name><surname>Maranville</surname><given-names>JC</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Ho</surname><given-names>JE</given-names></name><name><surname>Courchesne</surname><given-names>P</given-names></name><name><surname>Lyass</surname><given-names>A</given-names></name><name><surname>Larson</surname><given-names>MG</given-names></name><name><surname>Gieger</surname><given-names>C</given-names></name><name><surname>Graumann</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>AD</given-names></name><name><surname>Danesh</surname><given-names>J</given-names></name><name><surname>Runz</surname><given-names>H</given-names></name><name><surname>Hwang</surname><given-names>S-J</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Butterworth</surname><given-names>AS</given-names></name><name><surname>Suhre</surname><given-names>K</given-names></name><name><surname>Levy</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genome-wide mapping of plasma protein Qtls identifies Putatively causal genes and pathways for cardiovascular disease</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>3268</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-05512-x</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>X</given-names></name><name><surname>Lanza</surname><given-names>IR</given-names></name><name><surname>Swain</surname><given-names>JM</given-names></name><name><surname>Sarr</surname><given-names>MG</given-names></name><name><surname>Nair</surname><given-names>KS</given-names></name><name><surname>Jensen</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Adipocyte mitochondrial function is reduced in human obesity independent of fat cell size</article-title><source>The Journal of Clinical Endocrinology and Metabolism</source><volume>99</volume><fpage>E209</fpage><lpage>E216</lpage><pub-id pub-id-type="doi">10.1210/jc.2013-3042</pub-id><pub-id pub-id-type="pmid">24276464</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Lv</surname><given-names>Y</given-names></name><name><surname>Di</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Kong</surname><given-names>X</given-names></name><name><surname>Sheng</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>M</given-names></name><name><surname>Lv</surname><given-names>S</given-names></name><name><surname>Qi</surname><given-names>H</given-names></name><name><surname>Gao</surname><given-names>M</given-names></name><name><surname>Liang</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Fu</surname><given-names>Z</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Ding</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mir-27B-3P regulation in Browning of human visceral Adipose related to central obesity</article-title><source>Obesity</source><volume>26</volume><fpage>387</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1002/oby.22104</pub-id><pub-id pub-id-type="pmid">29280351</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Gong</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Kolwicz</surname><given-names>SC</given-names></name><name><surname>Rabinovitch</surname><given-names>PS</given-names></name><name><surname>Tian</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Heart specific knockout of Ndufs4 ameliorates ischemia reperfusion injury</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>123</volume><fpage>38</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2018.08.022</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>W</given-names></name><name><surname>Gummesson</surname><given-names>A</given-names></name><name><surname>Tebani</surname><given-names>A</given-names></name><name><surname>Karlsson</surname><given-names>MJ</given-names></name><name><surname>Hong</surname><given-names>M-G</given-names></name><name><surname>Schwenk</surname><given-names>JM</given-names></name><name><surname>Edfors</surname><given-names>F</given-names></name><name><surname>Bergström</surname><given-names>G</given-names></name><name><surname>Fagerberg</surname><given-names>L</given-names></name><name><surname>Uhlén</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Whole-genome sequence Association analysis of blood proteins in a longitudinal wellness cohort</article-title><source>Genome Medicine</source><volume>12</volume><elocation-id>53</elocation-id><pub-id pub-id-type="doi">10.1186/s13073-020-00755-0</pub-id><pub-id pub-id-type="pmid">32576278</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Tian</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mitochondrial dysfunction in pathophysiology of heart failure</article-title><source>Journal of Clinical Investigation</source><volume>128</volume><fpage>3716</fpage><lpage>3726</lpage><pub-id pub-id-type="doi">10.1172/JCI120849</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Vinothkumar</surname><given-names>KR</given-names></name><name><surname>Hirst</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Structure of mammalian respiratory complex I</article-title><source>Nature</source><volume>536</volume><fpage>354</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1038/nature19095</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.82619.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ardehali</surname><given-names>Hossein</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/000e0be47</institution-id><institution>Northwestern University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.08.24.505177" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.08.24.505177"/></front-stub><body><p>This paper describing the genetic architecture of the heart mitochondrial proteome is important in that it identifies the major role of mitochondria in this process. The data is convincing, and appropriate and validated methodology in line with current state-of-the-art is used. This paper will be of interest to several groups of audiences, including cardiovascular researchers and geneticists.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.82619.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Ardehali</surname><given-names>Hossein</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/000e0be47</institution-id><institution>Northwestern University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.08.24.505177">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.08.24.505177v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Genetic Architecture of Heart Mitochondrial Proteome influencing Cardiac Hypertrophy&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by a Senior Editor. The following individual involved in the review of your submission has agreed to reveal their identity: Mathias Mericskay (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this letter to help you prepare a revised submission.</p><p>Essential revisions:</p><p>• It is not clear, at least to this reviewer, why the authors focused on NDUFS4. In the Results section, the authors mention: &quot;NDUFS4, a protein critical for complex-I assembly and loss of which leads to cardiac hypertrophy (2) mapped near the locus but outside the region of linkage disequilibrium. However, within the locus was the microRNA(miR)-23b/27b/24-1 cluster, among which miR-27b, a conserved regulator of NDUFS4, was identified via nine miRNA target prediction algorithms and one dataset of experimentally validated miRNA targets.&quot; If NDUFS4 is outside the range, why did the authors then focus on a microRNA that regulates this protein? The concept behind the focus on NDUFS4 is not clear and needs to be better explained.</p><p>• The western blot in Figure 2J is not convincing at all and the difference noted on the bar graph is not supported by the western blot.</p><p>• The authors do not describe the difference between mir27b-5p and mir27b-3p. This needs to be better described.</p><p>• Why does mir27b-5p decrease NDUFS4 compared to control in Figure 2J?</p><p>• It's not clear why the authors used MitoCarta 2.0 and not the more updated MitoCarta 3. An explanation for this decision would be appreciated. Regardless, it would be ideal to retroactively expand the analysis to MitoCarta 3.0.</p><p>Figure 2</p><p>• The correlation between miR-27b expression and heart weight is not impressive. Given that this is a key part of the mechanistic hypothesis underlying this correlative observation and the low magnitude and lack of statistical power of the effect in Figure 2H, this is a significant weakness.</p><p>• Apart from changes in heart size, it would be informative to assess hemodynamic cardiac characteristics such as ejection fraction to assess changes in cardiac function.</p><p>• Changes in protein abundance don't necessarily indicate changes in function, especially such small changes. Therefore, the addition of functional assays directly related to the protein would greatly enhance this paper. For example, the authors could examine changes in mitochondrial respiration or metabolism between treatments and genotypes.</p><p>• As a result of these issues, the authors' conclusion in lines 201-202 is not, in my opinion, adequately supported by the provided data. Figures 2H and 2I show a correlation. The cause-and-effect experiment of transfecting miR-27b into NRVM is not very impressive by itself. Adding a third replicate to the PE group may help show if there is a statistical difference; it's not clear why they have fewer replicates in this group. Primary ACM might be an alternative model system to show miR-27b increases NDUFS4 levels (although it would be more technically challenging). The researchers could also block miR-27b and if their hypothesis holds true should see a decrease in NDUF4.</p><p>Figure 3</p><p>• The lack of any functional assessments to strengthen the correlation, let alone actual causation experiments is clearly apparent. Please make the data for this figure to provide a functional assessment.</p><p>Overall</p><p>In lines 44-46 the impression was given that these three variations would cause heart weight changes in both ISO and DIO HF models. Unfortunately, only one of the three genes showed heart weight changes in both conditions.</p><p>Tissue slices showing the histology or functional imaging studies of the heart (both of which have been done previously by papers published by this group) would provide much stronger evidence that the genes they identify could play a role in causing/preventing heart failure. Are the changes in weight the authors see sufficient to cause/prevent heart failure? It would be a nice touch for the authors to include additional comments in this area in the discussion as some of the changes in weight are small.</p><p>• The size effect impact on cardiac hypertrophy is more difficult to appreciate as if I understand well only the data after ISO or DIO are shown for each allele but not baseline values. LV mass/body weight % of 0.4-0.45% as shown in Figure 2D does not suggest massive hypertrophy (0.4% = 100 mg LV for 25 g of body weight, for instance, can be seen in normal mice). The same holds true for figures 2E-F. I would like the authors to give the values of LV mass in untreated animals (is it similar between the 2 genotypes?) and maybe express the hypertrophy in relative increase to baseline in each group. In this way, one could better realize if the treatment was really efficient to trigger hypertrophy and how much the response differs between the groups.</p><p>• The same holds true for figures 3E-F and 4E-F: Is this clinically meaningful as the size effect seems to be very low? I would like the authors to discuss that point. Can the 3 loci have a cumulative effect? Is the study powered enough to detect that?</p><p>• Could the authors provide the level of other markers of hypertrophy from their protein screen such as BNP, Β-MHC (although difficult to distinguish from α-MHC by proteomic), or any other relevant protein? This would strengthen their hypothesis if the loci variant were also associated with quantitative differences in these classical markers of cardiac hypertrophy.</p><p>• sum up the values of mitochondria and lysate levels per individual to perform a statistical analysis of the total level of each coQ?</p><p>• If we admit that the total CoQ9 and CoQ10 levels are increased when COQ7 involved in their synthesis is reduced, it remains a puzzling observation. The authors discuss the possibility that CoQ is relocalized to the outer membrane or in the cytosol when COQ7 is reduced in heterozygotes CO7 mutant or in the mice bearing the rs32451909 GG allele, but this does not resolve the question of the total level of CoQ metabolite. Can the authors elaborate a bit further on that observation and by which mechanism it could occur? For instance, are the proteins involved in coQ degradation repressed when COQ7 is low?</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>This is a well-written paper and the data support the conclusion. As mentioned in the public review, the authors need to address a couple of concerns.</p><p>1. It is not clear, at least to this reviewer, why the authors focused on NDUFS4. In the Results section, the authors mention: &quot;NDUFS4, a protein critical for complex-I assembly and loss of which leads to cardiac hypertrophy (2) mapped near the locus but outside the region of linkage disequilibrium. However, within the locus was the microRNA(miR)-23b/27b/24-1 cluster, among which miR-27b, a conserved regulator of NDUFS4, was identified via nine miRNA target prediction algorithms and one dataset of experimentally validated miRNA targets.&quot; If NDUFS4 is outside the range, why did the authors then focus on a microRNA that regulates this protein? The concept behind the focus on NDUFS4 is not clear and needs to be better explained.</p><p>2. The western blot in Figure 2J is not convincing at all and the difference noted on the bar graph is not supported by the western blot.</p><p>3. The authors do not describe the difference between mir27b-5p and mir27b-3p. This needs to be better described.</p><p>4. Why does mir27b-5p decrease NDUFS4 compared to control in Figure 2J?</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>Figure 1</p><p>– It's not clear why the authors used MitoCarta 2.0 and not the more updated MitoCarta 3. An explanation for this decision would be appreciated. Regardless, it would be ideal to retroactively expand the analysis to MitoCarta 3.0.</p><p>Figure 2</p><p>– The correlation between miR-27b expression and heart weight is not impressive. Given that this is a key part of the mechanistic hypothesis underlying this correlative observation and the low magnitude and lack of statistical power of the effect in Figure 2H, this is a significant weakness.</p><p>– Similar to the above, changes in NDUFS4 protein levels in NRVM cells in response to PE and miR-27b are not very convincing. The authors are careful in their interpretation of increased NDUFS4 in miR-27b-3p, not claiming significance, but do not mention miR-27b-5p. It would be nice to mention the results of miR-27b-5p in the text.</p><p>– Apart from changes in heart size, it would be informative to assess hemodynamic cardiac characteristics such as ejection fraction to assess changes in cardiac function.</p><p>– Repeating this experiment in a more physiologically relevant model like primary cultured adult cardiomyocytes may help improve these data.</p><p>– Changes in protein abundance don't necessarily indicate changes in function, especially such small changes. Therefore, the addition of functional assays directly related to the protein would greatly enhance this paper. For example, the authors could examine changes in mitochondrial respiration or metabolism between treatments and genotypes.</p><p>– As a result of these issues, the authors' conclusion in lines 201-202 is not, in my opinion, adequately supported by the provided data. Figures 2H and 2I show a correlation. The cause-and-effect experiment of transfecting miR-27b into NRVM is not very impressive by itself. Adding a third replicate to the PE group may help show if there is a statistical difference; it's not clear why they have fewer replicates in this group. Primary ACM might be an alternative model system to show miR-27b increases NDUFS4 levels (although it would be more technically challenging). The researchers could also block miR-27b and if their hypothesis holds true should see a decrease in NDUF4.</p><p>Figure 3</p><p>– The authors could comment on whether patients with Leigh syndrome, French-Canadian type suffer from cardiomyopathies.</p><p>– The lack of any functional assessments to strengthen the correlation, let alone actual causation experiments is clearly apparent.</p><p>Figure 4</p><p>– Again, the lack of any functional assessments to strengthen the correlation, let alone actual causation experiments is clearly apparent.</p><p>Overall</p><p>– Regarding hypertrophy, I was given unmet expectations about the impact. In lines 44-46 I got the impression that these three variations would cause heart weight changes in both ISO and DIO HF models. Unfortunately, only one of the three genes showed heart weight changes in both conditions.</p><p>– Regarding heart failure, at the end of the abstract and the beginning of the intro, the focus is on the potential impact of this paper for identifying genes that might underlie genetic susceptibility to heart failure. The authors are cautious with their claims, which is good, but it would be nice to see more than weight measurements and see metrics that indicate heart failure in addition to hypertrophy. Either tissue slices showing the histology or functional imaging studies of the heart (both of which have been done previously by papers published by this group) would provide much stronger evidence that the genes they identify could play a role in causing/preventing heart failure. I am left wondering if the weight differences are relevant to pathologic or physiologic adaptations. Are the changes in weight the authors see sufficient to cause/prevent heart failure? It would be a nice touch for the authors to include additional comments in this area in the discussion as some of the changes in weight are small.</p><p>– The authors did a good job with their conclusion wrapping up their results with previously published biology. They stated their limitations and it is clear that the genes they identified still require more validation. They also do a good job summarizing the significance of this paper and their research, which is identifying genes that were only possible because they were looking at proteomics within their HMDP.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>1. I am not an expert in bioinformatics and pQTL identification, so I will not comment on that aspect and believe the hotspots identified are indeed strongly associated with the mitochondrial protein level. For instance, the size effect of the different rs48592660 allele on the protein level of the gene identified in the Ch13 locus is indeed important. However, the size effect impact on cardiac hypertrophy is more difficult to appreciate as if I understand well only the data after ISO or DIO are shown for each allele but not baseline values. LV mass/body weight % of 0.4-0.45% as shown in Figure 2D does not suggest massive hypertrophy (0.4% = 100 mg LV for 25 g of body weight, for instance, can be seen in normal mice). The same holds true for figure 2E-F. I would like the authors to give the values of LV mass in untreated animals (is it similar between the 2 genotypes?) and maybe express the hypertrophy in relative increase to baseline in each group. In this way, one could better realize if the treatment was really efficient to trigger hypertrophy and how much the response differs between the groups.</p><p>2. The same holds true for figures 3E-F and 4E-F, so finally, for all the loci described. My point is: Is this clinically meaningful as the size effect seems to be very low? I would like the authors to discuss that point. Can the 3 loci have a cumulative effect? Is the study powered enough to detect that?</p><p>3. Could the authors provide the level of other markers of hypertrophy from their protein screen such as BNP, Β-MHC (although difficult to distinguish from α-MHC by proteomic), or any other relevant protein? This would strengthen their hypothesis if the loci variant were also associated with quantitative differences in these classical markers of cardiac hypertrophy.</p><p>4. When looking at figure 4G, while CoQ9 and CoQ10 increase in the lysate, they do not decrease in the mitochondrial fraction, and if any trend should be seen, they rather increase there too, although I agree it's not significant. Could the authors sum up the values of mitochondria and lysate levels per individual to perform a statistical analysis of the total level of each coQ?</p><p>5. If we admit that the total CoQ9 and CoQ10 levels are increased when COQ7 involved in their synthesis is reduced, it remains a puzzling observation. The authors discuss the possibility that CoQ is relocalized to the outer membrane or in the cytosol when COQ7 is reduced in heterozygotes CO7 mutant or in the mice bearing the rs32451909 GG allele, but this does not resolve the question of the total level of CoQ metabolite. Can the authors elaborate a bit further on that observation and by which mechanism it could occur? For instance, are the proteins involved in coQ degradation repressed when COQ7 is low?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.82619.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>• It is not clear, at least to this reviewer, why the authors focused on NDUFS4. In the Results section, the authors mention: &quot;NDUFS4, a protein critical for complex-I assembly and loss of which leads to cardiac hypertrophy (2) mapped near the locus but outside the region of linkage disequilibrium. However, within the locus was the microRNA(miR)-23b/27b/24-1 cluster, among which miR-27b, a conserved regulator of NDUFS4, was identified via nine miRNA target prediction algorithms and one dataset of experimentally validated miRNA targets.&quot; If NDUFS4 is outside the range, why did the authors then focus on a microRNA that regulates this protein? The concept behind the focus on NDUFS4 is not clear and needs to be better explained.</p></disp-quote><p>The chr13 locus was highly enriched for mitochondrial complex-I, and among the three complex-I proteins encoded by chr13 (NDUFS4, NDUFS6 and NDUFAF2), only NDUFS4 protein levels were affected by chr13 locus. Therefore, we focused on NDUFS4.</p><disp-quote content-type="editor-comment"><p>• The western blot in Figure 2J is not convincing at all and the difference noted on the bar graph is not supported by the western blot.</p></disp-quote><p>We have independently repeated our experiments and have now revised the data with new blots and graphs (Figure 2J). We have also supplied source data of the blots as part of the peer review.</p><disp-quote content-type="editor-comment"><p>• The authors do not describe the difference between mir27b-5p and mir27b-3p. This needs to be better described.</p></disp-quote><p>We thank the reviewer for this comment and have included the following information in the revised manuscript.</p><p>“The precursor miR-27b has two mature arms: miR-27b-5p and miR-27b-3p that originates from the 5’ or 3’ strand of the precursor miR-27b, respectively and are almost complementary to each other. The stability and functionality of each arm depends on the tissue/cell type and according to miRBase Sequence database <sup>1</sup> (database of published miRNA sequences and annotation), miR-27b-3p (98.8%) is more abundant than miR-27b-5p (1.2%) and therefore is assumed to be the stable and functional version.”</p><disp-quote content-type="editor-comment"><p>• Why does mir27b-5p decrease NDUFS4 compared to control in Figure 2J?</p></disp-quote><p>As stated in response to #3, since <italic>miR-27b-5p</italic> and <italic>miR-27b-3p</italic> are almost complementary to each other, it is not surprising that <italic>miR-27b-5p</italic> decrease NDUFS4. However, as stated in response to #3, only <italic>miR-27b-3p</italic> is abundant in vivo.</p><disp-quote content-type="editor-comment"><p>• It's not clear why the authors used MitoCarta 2.0 and not the more updated MitoCarta 3. An explanation for this decision would be appreciated. Regardless, it would be ideal to retroactively expand the analysis to MitoCarta 3.0.</p></disp-quote><p>We have now retroactively expanded the analyses to MitoCarta 3.0. Overall, the reanalysis did not significantly deviate from our original findings. We identified a total of 848 nuclear-encoded mitochondrial proteins (original 840 proteins), but we did not uncover new <italic>trans­­</italic>-pQTL hotspots. Except the chr7 locus, the other two loci remained the same. Two proteins (MDH1 and TKT) disappeared from the chr7 locus, and one new protein (LDHB) appeared; however, the peak <italic>trans­­</italic>-pQTL SNP (rs32451909) and the candidate protein (COQ7) remained the same. These were reflected in revised Figures 4A-C. With respect to WGCNA, the same 5 modules reappeared with minor changes in protein composition. These were reflected in revised Figures 1B, 2B, 3B and 4B and in the main text.</p><disp-quote content-type="editor-comment"><p>Figure 2</p><p>• The correlation between miR-27b expression and heart weight is not impressive. Given that this is a key part of the mechanistic hypothesis underlying this correlative observation and the low magnitude and lack of statistical power of the effect in Figure 2H, this is a significant weakness.</p></disp-quote><p>The statistics included a few strains not belonging to either ‘AA’ or ‘GG’ genotypes but to an ‘AG’ group. After removing these, the correlation and P values were improved (bicor = -0.267 and p value = 0.02).</p><disp-quote content-type="editor-comment"><p>• Apart from changes in heart size, it would be informative to assess hemodynamic cardiac characteristics such as ejection fraction to assess changes in cardiac function.</p></disp-quote><p>We appreciate the reviewer’s comments. However, this is a population-based study of over 72 strains of mice and it was not feasible to perform detailed hemodynamic cardiac characteristics. The goal of the study was to understand the genetic regulation of heart hypertrophy and we feel that our current findings are significant in several respects. First, we identified three novel <italic>trans</italic>-regulatory genetic loci that control distinct classes of mitochondrial proteins as well as heart hypertrophy using an integrative proteomics approach. Each of these loci contains mitochondrial proteins previously shown to affect heart pathophysiology but by unknown mechanisms (<italic>miR-27b</italic>/NDUFS4 <sup>2-4</sup>, LRPPRC <sup>5</sup> and COQ7 <sup>6</sup>). Also, each of these three <italic>trans</italic>-regulating hotspots were specific for the proteome, as they were not identified in our heart transcriptome. Further, we used both experimental and statistical analyses to support their causal roles. Our results provide evidence that common variations of certain mitochondrial proteins can act in <italic>trans</italic> to influence mitochondrial functions and contribute to heart hypertrophy. Of course, in-depth investigations such as hemodynamic cardiac assessments would be informative, but we humbly believe it is beyond the scope of the current paper.</p><disp-quote content-type="editor-comment"><p>• Changes in protein abundance don't necessarily indicate changes in function, especially such small changes. Therefore, the addition of functional assays directly related to the protein would greatly enhance this paper. For example, the authors could examine changes in mitochondrial respiration or metabolism between treatments and genotypes.</p></disp-quote><p>As in the previous point, we believe it is beyond the scope of the current paper. We emphasize that this is a population-based study of over 72 strains of mice, and it was not feasible to perform detailed cardiac characteristics.</p><disp-quote content-type="editor-comment"><p>• As a result of these issues, the authors' conclusion in lines 201-202 is not, in my opinion, adequately supported by the provided data. Figures 2H and 2I show a correlation. The cause-and-effect experiment of transfecting miR-27b into NRVM is not very impressive by itself. Adding a third replicate to the PE group may help show if there is a statistical difference; it's not clear why they have fewer replicates in this group. Primary ACM might be an alternative model system to show miR-27b increases NDUFS4 levels (although it would be more technically challenging). The researchers could also block miR-27b and if their hypothesis holds true should see a decrease in NDUF4.</p></disp-quote><p>As stated in response #2 listed for essential revisions, we have independently repeated our experiments and have now revised the data with new blots and graphs (Figure 2J). We have also supplied source data of the blots as part of the peer review.</p><disp-quote content-type="editor-comment"><p>Figure 3</p><p>• The lack of any functional assessments to strengthen the correlation, let alone actual causation experiments is clearly apparent. Please make the data for this figure to provide a functional assessment.</p></disp-quote><p>This is primarily a genetic study, that was intended for the Systems Genetics issue of <italic>eLife</italic>, rather than a physiological study of engineered mouse models. The findings relate to the identification of regulatory loci and pathways controlling a phenotype relevant to heart function. Of course, analysis of aspects such as ejection fraction would be important in further understanding the underlying mechanisms, but we feel that this is beyond the scope of the paper.</p><disp-quote content-type="editor-comment"><p>Overall</p><p>In lines 44-46 the impression was given that these three variations would cause heart weight changes in both ISO and DIO HF models. Unfortunately, only one of the three genes showed heart weight changes in both conditions.</p></disp-quote><p>We have now revised the main text.</p><p>“Variations of all three were associated with heart mass in one of two independent heart stress models, namely, isoproterenol (ISO)-induced heart failure and diet-induced obesity (DIO) models.”</p><disp-quote content-type="editor-comment"><p>Tissue slices showing the histology or functional imaging studies of the heart (both of which have been done previously by papers published by this group) would provide much stronger evidence that the genes they identify could play a role in causing/preventing heart failure.</p></disp-quote><p>We appreciate the reviewer’s comments but emphasize that this is a population-based study of over 72 strains of mice, and it was not feasible to perform detailed cardiac characteristics. To go back and repeat the entire study, involving hundreds of strains and transcriptomics and proteomics analyses, is simply not feasible.</p><disp-quote content-type="editor-comment"><p>Are the changes in weight the authors see sufficient to cause/prevent heart failure? It would be a nice touch for the authors to include additional comments in this area in the discussion as some of the changes in weight are small.</p></disp-quote><p>We have now included percent changes between the two genotypes to better reflect the changes quantitatively.</p><disp-quote content-type="editor-comment"><p>• The size effect impact on cardiac hypertrophy is more difficult to appreciate as if I understand well only the data after ISO or DIO are shown for each allele but not baseline values. LV mass/body weight % of 0.4-0.45% as shown in Figure 2D does not suggest massive hypertrophy (0.4% = 100 mg LV for 25 g of body weight, for instance, can be seen in normal mice). The same holds true for figures 2E-F. I would like the authors to give the values of LV mass in untreated animals (is it similar between the 2 genotypes?) and maybe express the hypertrophy in relative increase to baseline in each group. In this way, one could better realize if the treatment was really efficient to trigger hypertrophy and how much the response differs between the groups.</p></disp-quote><p>We have now revised all figures to include both the control and ISO groups and the percent changes between the two genotypes in each group to better reflect the changes quantitatively.</p><disp-quote content-type="editor-comment"><p>• The same holds true for figures 3E-F and 4E-F: Is this clinically meaningful as the size effect seems to be very low? I would like the authors to discuss that point.</p></disp-quote><p>We have now included percent changes between the two genotypes to better reflect the changes quantitatively but since heart failure is undoubtedly a complex trait, involving hundreds of genes each with very small effect sizes, it is important to characterize modest as well as large effects. We now discuss this point in the manuscript.</p><p>“Nevertheless, the percent change in heart mass between the three loci were only of modest value. However, both heart failure and hypertrophy being complex traits are influenced by a large number of genetic factors, each exerting a small to large effect. The resulting phenotypes are therefore a sum of all impacts. So, we believe it is important to characterize modest as well as large effects.”</p><disp-quote content-type="editor-comment"><p>Can the 3 loci have a cumulative effect? Is the study powered enough to detect that?</p></disp-quote><p>Yes, the 3 loci have an additive effect. The analysis we did was the following:</p><p>a) For each of the three loci, the mean heart weight (both raw and normalized) for each of the genotypes were calculated, and then the difference between the highest and lowest homozygous groups were found.</p><p>b) Sum these differences for all three of the loci to get the expected difference between the genotype combination with the lowest theoretical heart weight and the one with the highest theoretical heart weight.</p><p>c) This expected difference to the heart weight from the genotype combination were then added with the lowest theoretical heart weight to see how different it is from the heart weight from the genotype combination with the highest theoretical heart weight.</p><p>For example, from the chow dataset, the differences in raw heart weight for the homozygous groups are the following:</p><p>chr7: 0.013 (0.127 [GG] – 0.114 [AA])</p><p>chr13: 0.015 (0.128 [AA] – 0.113 [GG])</p><p>chr17: 0.004 (0.120 [GG] – 0.116 [TT])</p><p>which leads to an expected shift of ~0.032.</p><p>The AA, GG, TT combination has a mean heart weight of 0.112, so the expected heart weight for the GG, AA, GG combination is 0.144. The actual weight is 0.139, so taking (observed – expected) / expected * 100 gives an error of ~5%.</p><p>For raw heart weights, the % errors are as follows:</p><p>chow_female HFHS_female HFHS_male Iso_treated</p><p>-5.017749 -2.902519 -7.117292 -3.281568</p><p>For normalized heart weights, the % errors are as follows:</p><p>chow_female HFHS_female HFHS_male Iso_treated</p><p>-6.993903 -2.239902 1.728702 -2.803209</p><p>This is consistent with an additive model.</p><disp-quote content-type="editor-comment"><p>• Could the authors provide the level of other markers of hypertrophy from their protein screen such as BNP, Β-MHC (although difficult to distinguish from α-MHC by proteomic), or any other relevant protein? This would strengthen their hypothesis if the loci variant were also associated with quantitative differences in these classical markers of cardiac hypertrophy.</p></disp-quote><p>We computed correlations between the three candidate proteins and known hypertrophic markers (NPPA and MYH7) and the results are included in table S10 in the manuscript.</p><disp-quote content-type="editor-comment"><p>• sum up the values of mitochondria and lysate levels per individual to perform a statistical analysis of the total level of each coQ?</p></disp-quote><p>We have revised Figure 2J to include the sum of mitochondria and lysate levels and they were still significant between the genotypes.</p><disp-quote content-type="editor-comment"><p>• If we admit that the total CoQ9 and CoQ10 levels are increased when COQ7 involved in their synthesis is reduced, it remains a puzzling observation. The authors discuss the possibility that CoQ is relocalized to the outer membrane or in the cytosol when COQ7 is reduced in heterozygotes CO7 mutant or in the mice bearing the rs32451909 GG allele, but this does not resolve the question of the total level of CoQ metabolite. Can the authors elaborate a bit further on that observation and by which mechanism it could occur? For instance, are the proteins involved in coQ degradation repressed when COQ7 is low?</p></disp-quote><p>We agree with the reviewer that this is puzzling but do not believe that these details are known.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>Figure 3</p><p>– The authors could comment on whether patients with Leigh syndrome, French-Canadian type suffer from cardiomyopathies.</p></disp-quote><p>LSFC patients usually present symptoms during the first year of their life and their average life expectancy is four to six years. However, in some cases, the patients exhibit cardiomyopathies. We have now included the following in the main text as a response to the reviewer’s comment.</p><p>“Loss of function mutations in LRPPRC cause a congenital mitochondrial disease called Leigh syndrome, French-Canadian type that is often characterized by mitochondrial complex IV deficiency and impaired mitochondrial respiration and in some cases, neonatal cardiomyopathy and congenital cardiac abnormalities have been reported <sup>5,7</sup>.”</p></body></sub-article></article>